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The cell membrane serves as a barrier between the interior and exterior of a living 
cell. Its main structural component is the lipid bilayer, which is composed of various kinds 
of lipids that segregate into domains. These lipid domains, distinguished in composition 
and physical properties from the bulk lipids that surround them, are believed to modulate 
the function of resident proteins by providing an appropriate lipid environment. 
Polyunsaturated fatty acids (PUFA) are a type of fatty acid that contain multiple C=C 
double bonds. They have a lot of health benefits, which may originate in part due to their 
incorporation into lipids in the plasma membrane. Hypotheses that PUFA-containing lipids 
laterally separate into domains and/or modulate the structure of existing domains have been 
raised to explain the fundamental role played by PUFA. In our research, we use molecular 
dynamics (MD) simulations to simulate model membranes composed of PUFA-containing 
phospholipids and to investigate their interaction with cholesterol and vitamin E that are 
influential membrane constituents.  
The presumptive function for vitamin E in membranes is to protect PUFA against 
oxidation. Although the chemistry of the process is well established, the role played by the 
molecular structure that we address with atomistic molecular dynamics (MD) simulations 
remains controversial. We compared the behavior of vitamin E in lipid bilayers composed 
of 1-stearoyl-2-docosahexaenoylphosphatidylcholine (SDPC, 18:0-22-6PC) and 1-
stearoyl-2-oleoylphosphatidylcholine (SOPC, 18:0-18:1PC) via all-atom MD simulations 
at 37° C. SDPC represents a PUFA-containing lipid, and SOPC serves as monounsaturated 
control. From the calculation of van der Waals energy of interaction between vitamin E 
and fatty acid (FA) chains, we found higher probability that the PUFA chains surround the 
chromanol head group on vitamin E. This is further demonstrated by probability density 
maps of acyl chains around vitamin E molecules. Also, an ability to more easily penetrate 
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deep into the PUFA containing bilayer of vitamin E is detected by faster flip-flop rate of 
vitamin E observed in the SDPC bilayers. These results showed that the high disorder of 
polyunsaturated docosahexaenoic acid (DHA) chains allows vitamin E to easily tunnel 
down into the bilayer and often brings the PUFA chains up to the surface of the bilayer, 
improving the likelihood that the reactive (hydroxyl) group on vitamin E would encounter 
a lipid peroxyl radical and terminate the oxidation process. Thus, the simulations indicate 
that the molecular structure of vitamin E supports its role as an antioxidant in a PUFA-
containing membrane. 
A subsequent study on the partitioning of vitamin E into PUFA-containing lipids 
was done by analyzing the binding energy of vitamin E in the corresponding lipid bilayer. 
The binding energy is obtained from the potential of mean force (PMF) profile of vitamin 
E alone the membrane normal direction (z), which is calculated from umbrella sampling 
MD simulations. We found the binding in SDPC is smaller in SOPC, indicating that 
vitamin E does not prefer PUFA-containing phospholipids. The flip-flop rate was also 
estimated from the PMF profile, confirming that vitamin E flip-flops across the SDPC 
bilayer more easily than the SOPC bilayer. From the simulations it was noted that the 
membrane deforms as vitamin E is pulled out, which suggests interactions between the 
phospholipids contribute to the binding energy of the vitamin E. 
In a final study, a comparison was made between the effect on membrane 
organization of the three types of long chain omega-3 (n-3) PUFA found in fish oils: 
eicosapentaenoic acid (EPA, 20:5), DHA (22:6) and docosapentaenoic acid (DPA, 22:5). 
MD simulations were run on lipid bilayers composed of 1-stearoyl-2-
eicosapentaenoylphosphatidylcholine (EPA-PC, 18:0-20:5PC), 1-stearoyl-2-
docosapentaenoylphosphatidylcholine (DPA-PC, 18:0-22:5PC), SDPC (DHA-PC, 18:0-
22:6PC) and, as a monounsaturated control, SOPC (OA-PC, 18:0-18:1PC) in the absence 
and presence of cholesterol. By analyzing the physical properties such as membrane order 
and thickness, we found all three n-3 PUFAs disorder the membrane. The disordering is 
greatest with EPA and least with DPA. Unique among the n-3 PUFA-containing 
membranes, there is region of high order in the upper portion of the DPA chain. The PUFA-
containing lipids were found to less favorably interact with cholesterol compared to the  
xiv 
 
OA-containing lipid, which is caused by their disorder. We speculate that differences 
between DPA, DHA and EPA might potentially modulate their effect on lipid domain 
formation.
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CHAPTER 1. CELL MEMBRANES AND POLYUNSATURATED 
FATTY ACIDS 
The cell membrane, also called plasma membrane, serves as a barrier between the interior 
and exterior of a living cell and cellar organelles in eukaryotes [1]. Its main structural 
component is a bilayer of lipid molecules about 5 nm in thickness. Membrane proteins, 
carbohydrates and other biological molecules are also embedded or inserted in this lipid 
bilayer. The real plasma membrane then is associated with a lot of biological functions, 
such as cell signaling [2], endocytosis [3], ion transportation [4], and so on.  
There is a great complexity in cell membranes. Many types of lipids and membrane 
proteins exist, and the corresponding number of types of lipid-lipid, lipid-protein and 
protein-protein interactions are diverse. The cell membrane itself is also a very dynamic 
system, which is a key for the role it plays in cellar processes [5]. All these facts make it a 
challenging task to understand the structure and dynamics of cell membrane accurately.  
One way to study the fundamental properties of cell membrane is to investigate on a 
simpler lipid-only bilayer system which is called a model membrane. Model membranes 
are protein-free with a controlled lipid content [6]. In this thesis we focus on the influence 
of polyunsaturated fatty acid (PUFA) incorporated into lipids in model membranes. The 
PUFAs are a type of fatty acids that contain multiple C=C double bonds. They have a lot 
of health benefits, which may originate from their physical properties [7]. In our research, 
we use molecular dynamics (MD) simulations to simulate model membranes composed of 
PUFA-containing phospholipids. Especially we investigated their interaction with 
cholesterol and vitamin E that are influential membrane constituents. 
1.1 Cell membranes 
The existence of cell membranes became accepted in the early 20 th century [8]. In 1925, 
the basic structure of cell membranes was revealed by Gorter and Grendel with a famous 
experiment [9]. They compared the surface area of the plasma membrane measured 
microscopically from mammalian erythrocytes with the area measured by spreading it out 
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as a lipid monolayer at an air/saline interface. The ratio between these two areas is 
approximately 1:2, so that the hypothesis of the bilayer structure of plasma membrane was 
established. Based on the lipid bilayer model, the fluid mosaic model was subsequently 
proposed [10] to further explain the organization and structure of plasma membranes in the 
1960-1970s. In this model, the lipid molecules tend to form bilayer structure in water 
solution driven by their amphiphilic properties. By this we mean their hydrophobic tails 
are embedded in the center of the bilayer avoiding contact with water and their hydrophilic 
head groups are exposed at the aqueous interface interacting with water. Membrane 
proteins are bound to the bilayer. The proteins, lipid molecules and a small amount of 
carbohydrates together form a two dimensional fluid matrix that comprises the plasma 
membrane. The fluidity of the membrane is provided by the lipid molecules. Membrane 
proteins diffuse laterally within the bilayer (Fig. 1.1a).  
More recently, the fluid mosaic model has been revised. Different types of lipids in the 
plasma membrane are no longer thought to be homogenously distributed. Patches of lipids 
called lipid domains are formed in the membrane that are different from the “average” 
lipids in composition and physical properties. Lipid domains were first identified in model 
membranes by Jain and White in 1977 [11], and then further confirmed by Karnovsky in 
1982 [12]. Now, the concept of inhomogeneous distribution of lipids in the plasma 
membrane is well accepted. Some membrane proteins have their conformation sensitive to 
the lipid local environment, so that the specific local environment provided by the lipid 
domains is essential for resident proteins to perform their functions [13] (Fig. 1.1b).  
1.2 Lipids 
Lipids constitute the fundamental structural component of plasma membrane. The major 
types of lipid molecule in animal plasma membrane are the phospholipids, sphingolipids 
and cholesterol. 
1.2.1 Phospholipids 
The chemical structure of 1-stearoyl-2-oleoyl phosphatidylcholine (18:0-18:1 PC), a 
typical phospholipid, is shown in Fig. 1.2a. It is composed of a hydrophilic head group and 
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two hydrophobic fatty acyl (FA) chains, all attached to a glycerol backbone. With different 
combinations of various head groups and FA chains, there are many kinds of phospholipid. 
The head group is attached at the sn-3 position of the glycerol back bone. The most 
common type of phospholipid found in animal plasma membranes is phosphatidylcholine 
(PC) with a phosphorylcholine head group. Phosphatidylethanolamine (PE) with a 
phosphorylethanolamine head group, and phosphatidylserine (PS) with a phosphorylserine 
head group are other examples [14].  
The hydrocarbon FA chains have an even number of carbons and are ester-linked at the sn-
1 and sn-2 positions of the glycerol back bone. The length of FA chains typically varies 
from 14 to 22 carbons, and the number of C=C bonds varies from 1 to 6. In the plasma 
membrane, the sn-1 chain is usually saturated (no double bonds) while the sn-2 chain is 
unsaturated (Fig. 1.2a). Less common PUFA are also typically incorporated at the sn-2 
position (Fig. 1.2b), although in some extreme cases they are found at both positions [15]. 
Stearic acid (SA 18:0) with 18 carbons is one of the most common saturated long FA 
attached at sn-1 position of phospholipids. Oleic acid (OA 18:1) with 18 carbons and 1 
double bond is the most common unsaturated FA chain attached at the sn-2 position.  
Both the types of head groups and FA chains determine the behavior/dynamic properties 
of a phospholipid in the membrane, which affect the physical property of the corresponding 
membrane lipid environment. In our studies we mostly focused on how FA chains affect 
the physical properties of model membranes. 
1.2.2 Sphingolipids 
Sphingomyelin (SM) is the main type of sphingolipid in plasma membranes. Its chemical 
structure contains three parts: a sphingosine backbone, a FA chain and a phosphocholine 
head group (Fig. 1.2c). The sphingosine backbone has a “sn-1 like” saturated chain with a 
trans C=C bond near the top, and is esterified to a phosphocholine group and amide-linked 
to a “sn-2 like” FA chain. The “sn-2 like” FA chain is usually saturated, which is different 
from the common phospholipids. SM has greater affinity to cholesterol compared to bulk 
lipids. The planar structure of cholesterol (will be discussed later) results in strong van der 
Waals interaction with the long linear saturated FA chains on SM, and there is hydrogen 
bonding between the hydroxyl group on the sterol and the amide group on the sphingosine 
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backbone [16]. This association between SM and cholesterol is responsible for the 
formation of lipid raft domains that are enriched with SM and cholesterol. Raft domains 
have different physical properties from the bulk lipids region, serving as the platform for 
signaling proteins [17].  
1.2.3 Cholesterol 
Cholesterol is the major type of sterol lipid in animal plasma membranes. It can make up 
as much as 50 mol% of total lipid in some cases [18]. The chemical structure of cholesterol 
molecule is shown in Fig 1.3a. The main structural component is a rigid tetracyclic moiety 
with a short branched chain at one end. A hydroxyl group at the other end of the sterol ring 
provides the amphiphilic feature for the molecule. Inside a membrane the hydroxyl group 
is usually located near the aqueous interface, while the long molecular axis of the molecule 
lies almost parallel to the membrane normal and extends towards the middle of the 
membrane. The planar structure of the sterol ring is asymmetric due to the two methyl 
substituents at the C10 and C13 position that stick out on one side. In this case we call the 
smooth side the α face, and the other (bumpy) side is called the β face. Cholesterol plays 
an important role in modulating membrane physical properties and lipid domain formation 
[19, 20]. By restricting the motion of neighboring FA chains, cholesterol increases 
membrane order and so stiffens the membrane. It is considered to be essential for function 
[21]. 
1.3 Model membranes 
1.3.1 Single component model membrane 
Model membranes are lipid bilayers prepared with controlled lipid content [6]. Their study 
can help elucidate the structure and organization of regions lipid bilayer that exist in certain 
region of real plasma membranes. The bilayers are hydrated, so that the lipid polar head 
groups are confined at the aqueous interface and the FA chains comprise the hydrophobic 
interior. Model membranes composed of a single phospholipid have different phases at 
different temperatures [22]. Under physiological temperature, a liquid-crystalline phase in 
which the FA chains are melted and undergo a lot of motion is usually adopted. The 
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dynamic properties of the FA chains are responsible for a range of physical features of 
phospholipid membranes, such as mechanical properties [23], phase behaviors [24, 25] and 
lipid domain formation. These features work collectively to influence the biological 
function of the plasma membrane.  
There are many experimental methods used to explore the dynamic properties of FA chains 
in model membranes. NMR spectroscopies, in particular, have been successfully applied. 
They are non-destructive, and directly measure the dynamic properties of the associated 
atoms/molecule moieties on different time scales. Among them, solid state 2H NMR is 
frequently used to investigate the molecular organization of the FA chains in hydrated 
model membrane samples [26]. This method measures the degree of anisotropy, quantified 
in terms of an order parameter (SCD), of the motion of lipid chain segments in which 
hydrogen is replaced by deuterium. The profile of SCD along a lipid chain is an important 
indicator of lipid structural and dynamical characteristics, and is correlated with other 
properties like hydrocarbon thickness, membrane rigidity and area expansion modulus, 
elastic properties (compressibility) and phase transition properties [27]. The definition of 
SCD is  
                                             𝑆"# = %& 3𝑐𝑜𝑠&𝛽 − 1                                               (1.1) 
where 𝛽 is the angle between the carbon-deuterium bond and membrane normal, and the 
angular bracket refers to a time average. It is a function of carbon position along a FA chain, 
usually falling between 0-0.5 in magnitude since in most cases 𝛽 =90˚ is the most probable 
orientation. The lower value is associated with greater isotropic motion (most disorder), 
while the upper value is associated with a lipid chain undergoing axial rotation in all-trans 
conformation (most order). However, there exist some situations, such as the carbon 
position on the cis double bond in in an oleic acid (18:1) chain where 𝛽 =90˚ is not most 
probable, in which case SCD is also involves a geometrical factor. 
The profile of SCD along the perdeuterated sn-1 chain in [2H35] stearoyl-2-oleoyl 
phosphatidylcholine (SOPC-d35) is shown in Figure 1.3a. Its shape is typical of membranes 
in the liquid crystalline state. The SCD values were calculated from the quadrupole splitting 
of peaks assigned to deuterium atoms. The profile starts with a plateau region of slowly 
decreasing order parameters in the upper portion of the chain (C2-C9), and then order 
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decreases progressively move quickly in the lower portion (C10-C18). It reflected that the 
motion of the top part of the chain is restricted, mainly staying parallel to the membrane 
normal while undergoing fast axial rotation. In the bottom half of the chain towards the 
center of bilayer, the motion becomes less restricted and there is an increase in the 
probability of gauche segments. Ultimately, the methyl group at the end of the chain moves 
almost isotropically and has a very low SCD.  
Order parameter profiles derived from MD simulation reproduce the experimental data. 
The profile shown for SOPC (Figure 1.4b) follows the same trend as the one from NMR 
(Figure 1.3a) except at the top region (C2-C9). This is because the SCD values from the MD 
simulations are calculated explicitly from each carbon position, so the profile contains 
detail missed in the smoothed profile from NMR that assumes order varies monotonically 
with position. In practice, 2H NMR SCD profiles are often used to validate MD simulations. 
1.3.2 Cholesterol’s effect on model membrane 
Cholesterol restricts the reorientation of phospholipid chains in liquid-crystalline phase. 
The profile obtained in MD simulations of SCD along the sn-1 chain in SOPC in the 
presence of 20 mol% cholesterol is an example of this ordering effect (Figure 1.4b). There 
is an increase of 40% in the average order. The increase in SCD is greater in the upper 
portion of the chain, which reflects the constraints imposed by the rigid steroid moiety that 
sits approximately parallel to the bilayer normal with its hydroxyl group near the aqueous 
interface. A higher cholesterol content (> 30 mol%), a liquid ordered phase (lo) is formed 
in which the chains are largely extended in all–trans conformation and undergo fast axial 
rotation. 
1.3.3 Mixtures of lipids – lipid domains 
Mixtures of saturated phospholipid, unsaturated phospholipid and cholesterol crudely 
mimic the lipid composition of biological membranes. They trend to separate into domains 
that are enriched in saturated phospholipid but depleted in cholesterol. These domains are 
believed to form in real membranes and provide the environment to support the function 
of resident proteins. 
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The lipid raft is the lipid domain that has been most studied [28]. It is a liquid ordered (lo) 
region ranging from 10-200 nm in size, that is enriched in cholesterol and saturated 
sphingomyelin. The rigid steroid moiety on the cholesterol stiffens the long saturated 
chains on sphingomyelin, causing the raft to be more ordered, thicker and less fluid 
compared with the surrounding bulk lipid region that is more unsaturated. Signaling 
proteins that are anchored in lipid rafts are purported to become functional when lipid rafts 
cluster together [29]. Thus the dynamics, size and stabilization of lipid rafts is a topic that 
receives a lot of attention. 
1.4 PUFA 
1.4.1 Molecular structure 
PUFA contain multiple (≥3) double bonds in a repeating =C-C-C= unit (Fig. 1.3c). They 
cannot be synthesized in mammals, but are required to maintain health. Designated 
according to the position of the final double bond relative to the terminal methyl, there are 
2 categories: omega-3 and omega-6. The former means the last double bond is at the 3rd 
carbon from the omega terminal methyl end of the chain, while omega-6 means that the 
last double bond is at the 6th carbon from the end. Numerous health benefits are associated 
with dietary consumption of n-3 PUFA found in fish oils [30]. The mechanism remains 
unclear and is the subject of ongoing investigation. Incorporation of n-3 PUFA into 
membrane phospholipids, which then modulate molecular organization and, as a result, 
protein activity is one possibility [31].  
1.4.2 Membrane properties 
Unlike saturated FA, PUFA are highly disordered. There is a shallow energy barrier for the 
dihedral rotation of C-C bonds next to the C=C bond, which produces a chain that is highly 
flexible. It can explore its whole conformational space within 50 ns by rapid isomerization 
[32]. Compared to more common saturated and mono-unsaturated chains, PUFA chains 
are able to adopt bent conformations that even have their lower portion moving up close to 
the aqueous interface [33, 34]. When incorporated into phospholipid, usually at the sn-2 
position, they alternate some basic physical properties of the bilayer. Compared to less 
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unsaturated FA-containing phospholipid bilayers, PUFA containing phospholipid bilayers 
have low lipid order, larger area per lipid, thinner membrane thickness, greater water 
permeability, and more fluidity.  
PUFA chains have poor affinity for cholesterol. Their rapid changes in conformation are 
unfavorable for close contact with the rigid steroid moiety of cholesterol. NMR and X-ray 
studies show a lower solubility for cholesterol in polyunsaturated phospholipid membrane, 
and binding coefficients measured for cholesterol are reduced in polyunsaturated bilayers 
[35]. MD simulations indicate cholesterol prefers the saturated (stearoyl, 18:0) sn-1 chain 
over the polyunsaturated (docosahexaenoyl, 22:6) sn-2 chain in a mixed chain PC [36].  
The high disorder of PUFA and their aversion for cholesterol have given rise to the 
hypothesis that modulation of the architecture of the plasma membrane may, in part, 
explain the biological function of PUFA. One model has domains forming that are enriched 
in PUFA-containing phospholipids but depleted in the sterol [37]. A cartoon illustrating 
this model is shown in Figure 1.4. It is based upon the results of a series of experiments on 
docosahexaenoic acid (DHA, 22:6)-containing PE [38-40]. The basic idea is that the PUFA 
enriched domain provide a platform for suitable proteins that require a disordered 
environment to function [37]. However, other models that suggest PUFA target lipid rafts 
– modifying their molecular architecture - have also been proposed. The matter, thus, is 
still under debate. 
1.4.3 Vitamin E 
Alpha tocopherol (αtoc) is the biologically active form of vitamin E that is retained in the 
human body. It is the major lipid soluble, chain-breaking anti-oxidant that protects 
polyunsaturated phospholipids from oxidation by terminating a chemical chain reaction by 
which oxidation propagates [41, 42]. The chemical structure of αtoc is shown in Fig. 1.3b. 
Similar to cholesterol, αtoc’s major structural components are a rigid head group with a 
polar hydroxyl group at one end and a hydrophobic chain at the other end. The difference 
is that the chromanol head group on αtoc is smaller than the steroid moiety on cholesterol, 
and the phytyl side (16 carbons) chain on αtoc is longer than the branched chain (5 carbons) 
on the sterol. The hydroxyl on the chromanol group is responsible for αtoc’s anti-oxidant 
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function. It needs to come into close contact with a lipid peroxyl radical to scavenge it 
before it attacks another lipid.  
1.5 Aims of research 
1.5.1 Interaction of α-tocopherol with a polyunsaturated phospholipid 
In conventional all-atom MD simulations and umbrella sampling MD simulations, we 
investigated the molecular organization and binding of αtoc in model membranes 
composed of a PUFA-containing lipid. We compared the interaction of αtoc with 1-steroyl-
2-docosahexaenoyl phosphatidylcholine (SDPC) and 1-stearoly-2-oleoyl 
phosphatidylcholine (SOPC). SDPC is polyunsaturated while SOPC is a monounsaturated 
control. 
While the chemistry of how αtoc works as an antioxidant has been extensively studied [43], 
the role its molecular structure plays is unclear. Whether it preferentially interacts with 
PUFA-containing phospholipids that are most susceptible to oxidation remains 
unanswered. This question is addressed in Chapter 3 and 4. Chapter 3 presents the results 
from all-atom MD simulations of the molecular organization of αtoc in an SDPC bilayer. 
In Chapter 4 the binding of αtoc to SDPC is measured by umbrella sampling MD 
simulations. 
1.5.2 EPA vs DHA vs DPA 
DHA has most often been studied as representative of n-3 PUFAs. In fact, EPA (20:5) and 
DPA (22:5) are also long-chain n-3 PUFAs found in fish oils that appear in the diet and are 
taken up into membrane phospholipids [44]. These three n-3 PUFAs have similar chemical 
structures with slightly varying unsaturation and chain length (Fig. 1.3c). It is not clear if 
they differ in their effects [44, 45]. In Chapter 5 all-atom MD simulations of membranes 
comparing these three PUFAs and their interaction with cholesterol are reported. 
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a) 
 
b) 
Figure 1.1 
a) The fluid mosaic model of plasma membrane. Phospholipids (red head group and yellow 
chains), carbohydrate (green) and cholesterol (yellow rigid sterol) form the bilayer. 
Proteins (blue) inserted or embedded in the fluid bilayer.  
(https://upload.wikimedia.org/wikipedia/commons/d/da/Cell_membrane_detailed_diagra
m_en.svg) 
b) Lipid raft hypothesis. Raft domain (orange head group) associated with raft proteins are 
floating in a sea of bulk lipids (green head group).  
(http://molmod.ugent.be/subject/modeling-oxygen-diffusion-through-biological-lipid-
membranes-using-inverse-monte-carlo) 
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Figure 1.2 
Chemical structures of different lipids 
a) Phosphatidylcholine with 1- stearic (18:0 saturated) 2-oleic (18:1 unsaturated) chain.  
b) Phosphatidylcholine with 1- stearic (18:0 saturated) 2-docosahexanoic (22:6 
polyunsaturated) chain.  
c) Sphingosylphosphorylcholine with N-palmitoyl (16:0) D-erythro (18:1 trans unsatruated) 
chain. 
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Figure 1.3  
Chemical structures of a) Cholesterol. b) α-tochopherol (Vitamin E). c) Three types of n-3 
Polyunsaturated fatty acids (PUFAs). 
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Figure 1.4 
Sn-1 chain Order parameter (SCD) profile of SOPC. a) SCD of d-35 SOPC sample at 37°C 
from 2H NMR experiment. b) SCD of SOPC from NPT MD simulation at 37°C, 1 atm. red: 
Pure SOPC bilayer sample. Green: 80 mol% SOPC + 20 mol% cholesterol. 
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Figure 1.5 
A cartoon illustration of the model of domain formation enhanced by the depletion of 
cholesterol from PUFA containing lipids. On the upper panel is the raft protein siting in a 
lipid raft domain enriched with cholesterol and sphingomyelin. With the addition of PUFA 
(DHA) incorporated lipid, the cholesterols are further excluded from these PUFA lipids 
which co-localized into the “non-raft” domain. Thus the size and stability of lipid raft is 
enhanced. At the meantime, non-raft protein are also sitting in the PUFA enriched non-raft 
domain. 
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CHAPTER 2. MD SIMULATION 
Molecular dynamics (MD) simulation is a powerful tool to study biological systems on the 
molecular level. It was first introduced in protein folding research [1]. Then as computing 
power grew exponentially over the past few decades, MD simulations have been applied 
widely to a lot of molecular biological systems, including model membranes [2]. There are 
several types of MD simulations suitable for biological system on different scales of size 
and time, such as all-atom MD and coarse-grained MD. In our research on model 
membranes we chose to use all-atom MD simulations with explicit solution. They are able 
to give us a detailed description of how changes in the structure of phospholipid molecules 
affect molecular organization in a bilayer, although are limited on the scale of the 
simulation size and time. 
2.1 Standard atomistic simulation 
The starting point for simulations is to build the lipid bilayer at the atomic level. CHARMM 
GUI was used [3]. The initial structures for each lipid molecule are randomly selected from 
a corresponding lipid structural library [4], and the lateral location of each lipid molecule 
is randomized in the leaflet. Water molecules are also explicitly modeled (Figure 2.1). Then 
a summation (integral) of all the pairwise interactions for each atom in the system is 
performed to calculate the force acting on it. The interactions are calculated from a set of 
potential functions (“force field”) that we will discuss later. Once the force and acceleration 
for each atom at each time step can be calculated, Newton’s second law can be applied to 
generate the motion of atoms and to obtain their trajectories. 
In practice, the velocity Verlet integration method [5] is applied. This method works as 
follows. Suppose that at time frame n, the position of an atom is 𝑟/. The acceleration 𝑎/ is 
                  (2.1) 
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so that the position of the atom for next step is  
         (2.2) 
and the acceleration of that atom is given by the force acting on it through Newton’s second 
law 
          (2.3) 
The 𝑈23245  for an atom at frame n is a summation of the pairwise interaction potential 
energies accounting for the atoms in the rest of the system. The interaction potential energy 
function is the “force field” that we mentioned earlier.  In all our simulations, we have used 
the standard CHARMM C36 force [6] and its C36p modification for polyunsaturated fatty 
acids [7]. 
The potential energy function of the force field is generally considered in 2 parts: 
    𝑈23245 = 𝑈63/7 + 𝑈/3/963/7      (2.4) 
where  𝑈63/7  stands for the bonded interaction energy, and 𝑈/3/963/7  for non-bonded 
interaction. In the CHARMM force field, 𝑈63/7 takes the following form [8] 𝑈63/7 = 𝐾6(𝑏 − 𝑏=)&63/7? + 𝐾@(𝜃 − 𝜃=)&4/B5C? + 𝐾D 1 +7EFC7G45?cos(𝑛𝛾 − 𝛿) + 𝐾N(𝜑 − 𝜑=)&EPQG3QCG? + 𝐾RS(𝑟%,U − 𝑟%,UV)&RGCW9SG475W 									  (2.5) 
Figure 2.2 illustrates each term. The 1st term describes the bond stretching energy. It is 
approximated by a harmonic potential energy function with a force constant Kb, where 
is the bond length and b0 is the equilibrium value. The 2nd term describes the contribution 
to the energy from the angle between adjacent bonds. It is also approximated by a harmonic 
potential energy function with a force constant Kθ, in this case, where 𝜃  is the angle 
between 2 adjacent bonds and θ0 is the equilibrium value. The 3rd term, in which γ is the 
dihedral angle between the planes of atoms ABC and BCD, describes the constraint on 
rotation around bond BC. Because the rotation of a covalent bond usually has more than 
one equilibrium conformation, the dihedral potential energy is approximated by a cosine 
function. The number of minima in this energy function is represented by n and δ defines 
the location of the minima, while Kr is the force constant. The 4th term, which is called the 
improper dihedral angle potential, is applied to maintain the correct geometry of atoms. It 
is approximated by a harmonic potential function with a force constant Kφ, where angle 𝜑 
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is defined as the improper angle between the planes of atoms ABC and BCD while φ0 is 
the equilibrium value. The 5th term comprises an additional angular term that is called the 
Urey-Bradley potential. It is represented by a harmonic potential function in which KUB is 
the force constant, and  is the distance between atoms 1 and 3 on atom 2 in a triple of 
atoms and r1,3o is the equilibrium distance. The parameters in all of these energy functions 
were determined from empirical techniques and quantum mechanics calculation [6-8]. For 
MD simulations of lipid bilayers, the first three terms are the most important, while the last 
two terms are minor. 
The non-bonded interactions are basically divided into 2 parts. The first term describes the 
electrostatic interaction energy and the second term represents the van der Waals 
interaction (vdW) energy: 
     𝑈/3/963/7 = YZY[\GZ[E] + 𝜀E] _`abZ,[GZ[ %& − 2 _`abZ,[GZ[ dEe        (2.6) 
Here rij is the distance between the ith and jth atoms, and qi and qj are the respective charges 
on the ith and jth atoms. For atoms that are attached on covalent bonds, qi and qj are the 
partial charges that are assigned to them due to the separation of the positive and negative 
charge distribution on the covalent bond (Figure 2.3a). The dielectric constant 𝜀 is 1 in 
explicit solvent simulation. The vdW energy is approximated by the standard Lennard-
Jones 6-12 potential, where the term 𝜀E]  refers to the vdW energy at its minimum and 𝑅ghi E,] is the equilibrium distance (where vdW energy is minimum) (Figure 2.3b). Only 
atom pairs with atoms that are separated by more than 3 covalent bones are included in 
calculating non-bonded interactions.  To avoid the high computational cost associated with 
long-range non-bonded interaction, the vdW interaction and the short range electrostatic 
interactions are truncated by switching functions at a certain distance (10 Å). The long-
range contribution to the electrostatic interactions was calculated using the particle-mesh 
Ewald method [9]. 
The size of our simulation cell is limited to a patch of membrane containing about 100 lipid 
molecules. In order to deal with the atoms and molecules that are near the edge of the cell, 
a periodic boundary condition was applied. The idea is to duplicate the system along each 
axis in all directions, so that the simulation system is surrounded by its images (Figure 2.4). 
1,3r
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Whenever a molecule moves out of the boundary of the simulation box, the image of the 
molecule appears and moves in from the opposite side of the boundary. Also these images 
still contribute to the non-bounded interactions of the atoms in the original cell.  
To make our simulation better represent the real situation, we chose to use the constant 
number of particles, constant pressure and constant temperature (NPT) type of simulation. 
The pressure and temperature were kept at 1 atm. and 310 K, respectively, to correspond 
with the physiological conditions. The extended system algorithm with Nose-Hoover 
thermostat and Langevin piston was applied for temperature and pressure control. With 
this method, the system is coupled with an external pressure piston and heat reservoir. 
Additional degrees of freedom representing the pressure piston and heat reservoir were 
added to the Hamiltonian. The volume of the system and velocity of the atoms are scaled 
to maintain the pressure and temperature. While the volume is changing, the x-y directions 
of the simulation cell change together while the z direction changes independently [10-13].  
2.2 MD simulation on lipid membrane 
All-atom MD simulation has been successfully applied in the study of model membranes 
over the past few decades. In that time, the simulations have progressed dramatically in 
size, duration and sophistication. The major force fields parameterized for lipid simulation 
are GROMOS and CHARMM. The GROMOS force field is used in the GROMACS 
simulation software. It applies united atom models that represent the non-polar parts (CH, 
CH2 and CH3) to reach a greater efficiency. The CHARMM force field is used in 
CHARMM and NAMD simulation software. It applies explicit all-atom model for the lipid 
molecules, and has a more detailed description on the inter and intra molecular interactions 
[14]. We chose to use the CHARMM force field in our work.  
The original CHARMM lipid force field C22 was released in the early 1990’s [15]. It 
successfully reproduced experimental data in constant particle number, normal pressure 
and temperature (NPAT) ensemble simulations. In a series of simulations done on a 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) bilayer, the simulated SCD profile 
showed good agreement with experimental data from 2H NMR at an area per lipid (62.9 
Å2) measured by X-ray scattering (Figure 2.5) [16]. Another simulation on 1,2-dioleoyl-
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sn-phosphatidylcholine (DOPC) with 59.3 Å2 for the area per lipid reproduced neutron and 
X-ray scattering density profiles [17]. Subsequent refinements of the force field (as C27 
[18] and then C36 [19]) have improved the quality of simulations. Now good agreement 
with experiment is achieved in simulations run in NPT ensemble on patches of bilayer 
containing 100 or more lipid molecules for 200 ns or longer (Fig. 2.6). The C36 force field, 
for example, yields accurate head group areas for different types of lipid in NPT ensemble 
[19]. Simulations published for lipid-cholesterol systems are also able to reproduce 
experimental results [20, 21], as are the few reports of vitamin E in bilayers [22, 23] that 
qualitative agreed with experiments.  
MD simulations can provide a detailed visualization of molecular ongoing action in a 
membrane that is unattainable in experiment. Their purpose is no namely to replicate 
experiment. They played a crucial role in the development of understanding 
polyunsaturated phospholipids. Quantum mechanical calculations performed on vinyl-
methylene bonds revealed a low energy barrier for torsion [24]. The simulations then run 
on SDPC showed, as seen in experiment, low order parameters (SCD < 0.05) throughout 
most of the DHA chain at the sn-2 position (Fig. 2.6). They established that high disorder, 
and not a geometry that produces a low order parameter, was responsible. 
2.3 Umbrella sampling 
Whether α-tocopherol (α-toc) preferentially interacts with PUFA-containing lipids is one 
of the topics that our research intends to test. Details of the motivation will be described 
later. Here we introduce the technique that was used to calculate the binding energy of α-
toc to lipid bilayers using the potential of mean force (PMF). The PMF describes the free 
energy change of a system along a reaction coordinate. It can basically be expressed as a 
function of a reaction coordinate, which in the case of our system is chosen to be the 
distance z between the center of mass of the chromanol group in an α-toc molecule and the 
center of the membrane along the membrane normal direction [25] 
  ( ) ln ( )BG z k T P z=              (2.7) 
G(z) is the system free energy, or potential of mean force (PMF) along z, zeroed at arbitrary 
location. 𝑃(𝑧) is the probability density of the system as a function of its coordinate 𝑧 with 
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all possible conformations. 𝑘S is the Boltzmann constant and T is the temperature of the 
system. A schematic illustration of G(z) is shown as figure 2.6. The change in free energy 
(ΔG) of the system from 𝑧 = 𝑧CY (where the chromanol group of α-toc is at the equilibrium 
depth) to 𝑧 greater than the sum of mono-layer thickness plus the length of α-toc molecule 
(where the entire α-toc molecule is totally in water) should represent the free energy change 
in pulling the α-toc out from the lipid bilayer. 
It is usually impossible to get the fully sampled 𝑃(𝑧)  of a system in ordinary MD 
simulation because its time scale is too short. A poor sampling would especially happen 
when a free energy barrier exists along the 𝑧 coordinate, which would mean the system 
takes a very long time to evolve across the barrier only by the thermal energy. A solution 
to the problem is to apply a series of constraints on the system along 𝑧 to push the system 
through the energy barrier. This approach is called umbrella sampling [26]. In practice, the 
simulation is copied to multiple windows, and in each window there is a harmonic 
constraint on 𝑧 centered at different 𝑧 values. The constraint Wi(z) in window i is called the 
bias potential 
      𝑊E 𝑧 = 𝐾(𝑧 − 𝑧E)&         (2.8) 
where 𝑧E is the position of the center of the constraining potential in the i-th window. In 
our case, the distance between successive 𝑧E is 1 Å, and there are 45 windows as 𝑧E changes 
from 0 Å to 44 Å. The initial structures of the windows are prepared by a pulling simulation 
that uses an artificial force to pull α-toc from the center of bilayer to the water. When we 
get the trajectory from the pulling simulation, a snapshot of a conformation with its reaction 
coordinate 𝑧  close to 𝑧E  is then selected to represent the initial conformation of each 
window. By dividing 𝑧 into bins, we can obtain the probability distribution pil of bin l in 
window i, under the bias potential Wi. 
To calculate the unbiased probability distribution pl, the Weighted Histogram Analysis 
Method (WHAM) is then applied as follows [27]. Suppose pl is given, then the expected 
biased probability pil in window i and bin l can be written as 
    𝑝E5 = 𝑓E𝑐E5𝑝5                                 (2.9) 
where cil is a bias factor that is determined by the bias potential in window i 
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and fi is used to keep the {pil} in window i summed up to 1. 
 𝑓E = %pZqQqq                    (2.11) 
According to the maximum likelihood theorem [27], we can minimize the quantity A 
     𝐴 = − 𝑁Eln𝑓EvE − 𝑀5ln𝑝5x5       (2.12) 
to derive another equation for pl    
     𝑝5 = xqyZzZpZqZ         (2.13) 
Here S is the total number of windows, M is the total number of bins, Ni is the total number 
of counts in window i, and Ml is the total number of counts in bin l from all the windows.  
Equations (2.11) and (2.13) together form the traditional WHAM equations. Starting with 
an arbitrary set of {pl} and {fi}, and iteratively substituting them into these equations, we 
can finally get a set of {pl} and {fi} that satisfy both equations so that the WHAM equations 
are solved. However, the above method can be slow in reaching convergence. In order to 
optimize calculating pl, we use a variable substitution for fi 𝑔E = ln 𝑓E ∆𝑔E = 𝑔E}% − 𝑔E 
     𝑓E = exp ∆𝑔EE9%]%        (2.14) 
Substituting equation (2.14) into (2.12), we can get the 𝐴 as a function of ∆𝑔E 
      𝐴 ∆𝑔%, ∆𝑔&, …∆𝑔?9% = − 𝑁EvE& ∆𝑔EE9%]% − 𝑀55 ln xqyZpZq ∆BZZ[Z      (2.15) 
In practice, the 𝐴  is minimized by the Broyden–Fletcher–Goldfarb–Shanno (BFGS) 
method. After that, the unbiased probability {𝑝5} can be determined, and thus the potential 
of mean force at each bin l along 𝑧 can be calculated from equation (2.7).  
2.4 Applications of USMD simulation to lipid bilayers 
Profiles of PMF with respect to depth within a membrane have been reported for a range 
of membrane constituents on the basis of USMD simulations [28]. Cholesterol is a 
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membrane constituent, somewhat similar in structure to αtoc that is a focus in this thesis, 
for which PMF profiles have been published. Illustrative examples of estimates of binding 
energy that were obtained are presented in Table 2.1. As seen in experiments, they show 
cholesterol has greater affinity for more ordered, saturated lipids such as raft-forming SM 
than more disordered, unsaturated phospholipids. 
Just one PMF profile for vitamin E has been reported so far from USMD simulation [29]. 
The binding energy in 1,2-dipalmitoylphosphatidycholine (DPPC) that we estimate (by 
eyeball) from that PMF is approximately 18 kcal/mol.  
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Table 2.1 
Examples of PMF profile of cholesterol in different lipid membranes, obtained by all atom 
USMD simulations. Unit for the free energy is kcal/mol. Care should be taken when 
comparing the ∆𝐺 from simulations with different conditions (temperature, force field, and 
so on). 
 
 
 
 
 
 
 
 
 
 
 
Lipid Zhang et al. [30] (319K) 
Bennett et al. [31] 
(323K) 
Bennett et al. [32] 
(323K) 
POPC 12.1  18.6 
18:0 SM 14.5   
DPPC  19.1  
DAPC  16  
POPC+PSM (16:0 
SM)+Cholesterol 
1:1:1 
  31.5 
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Figure 2.1 
Snapshot of all atom model of lipid bilayer with explicit water. Lipid atoms are represented as 
van der Waals spheres, and water molecules are shown as contour surfaces. 
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Figure 2.2 
Illustration of CHARMM C36 bond energy terms. 
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Figure 2.3 
a). Partial charge distribution for the atoms in a PC lipid molecule due to the uneven charge 
distribution on the covalent bond and ion.  
b). Lennard-Jones potential, 𝑅ghi E,] and 𝜀E]. 
 
 
 
 
 
 
 
 
38 
 
 
 
Figure 2.4 
Illustration of periodic boundary condition with simulation box in the center, surrounded by its 
image.  
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Figure 2.5 
SCD for the sn-2 chain of DPPC from MD simulation using NPAT ensemble with different 
are per lipid: a) 59.3 and 62.9 Å2; b) 65.5 and 68.1 Å2. NMR experimental data are denoted 
by symbols in both figures.  
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Figure 2.6 
SCD for the sn-1 (left) and sn-2 (right) chain of SDPC bilayers, obtained from MD 
simulations using CHARMM force field C36 and C36p, compared with experiment. 
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Figure 2.7 
Schematic illustration of the potential of mean force (PMF, or G(z)) profile of αtoc in a 
lipid bilayer. The reaction coordinate z represent the membrane normal distace between 
the center of mass of the chromanol group and the center of the bilayer. 
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CHAPTER 3. ΑLPHA-TOCOPHEROL IS WELL-DESIGNED TO 
PROTECT POLYUNSATURATED PHOSPHOLIPIDS: MD 
SIMULATIONS 
3.1 Introduction 
α-Tocopherol (αtoc) is the form retained by the human body of a structurally related group 
of phenolic compounds that make up vitamin E [1,2]. It is a lipid soluble antioxidant that 
is an essential micronutrient. Symptoms of deficiency include, for example, neuromuscular 
abnormities [3]. There is overall consensus that a major function of αtoc is to prevent the 
oxidation of polyunsaturated lipids that are particularly vulnerable to free radical attack in 
subcellular and plasma membranes [2,4-6]. The chemistry is well established [7,8], but it 
remains to be seen whether a structural component exists in support of this role [5,9-11]. 
Here we present MD simulations that reveal αtoc is well designed to protect 
polyunsaturated lipids.  
The molecular structure of αtoc consists of a chromanol head group that is methylated at 
all three of the available positions on a benzene ring and to which a 16-carbon saturated 
phytyl chain is attached at the opposite end (Fig. 3.1). A hydroxyl group on the benzene 
ring is responsible for antioxidant activity [7,8]. This hydrophilic group usually sits near 
the aqueous interface, anchored to a membrane by the hydrophobic chain that extends 
towards the center [12,13]. There it scavenges lipid peroxyl radicals that rise up (“snorkel”) 
to the surface from the interior of the membrane via conformational isomerization, 
terminating the chain reaction by which lipid peroxidation proceeds. The same location 
provides easy access to polar reducing agents that regenerate αtoc. Polyunsaturated fatty 
acids (PUFA), notably docosahexaenoic acid (DHA, 22:6) with 6 double bonds, are an 
influential membrane constituent [14]. Their incorporation into phospholipids in plasma 
membranes has been proposed to be responsible for a vast array of health benefits attributed 
to dietary consumption of fish oils rich in PUFA [15-17], while they are abundant in the 
phospholipids of neural membranes and depletion from these specialized membranes 
results in functional impairment [18,19]. Extremely high disorder is the unique property 
that PUFA possess and by which polyunsaturated phospholipids modulate membrane 
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organization and protein activity [20-22]. The origin of the disorder is the presence of a 
repeating =CH-CH2-CH= unit within which the energy barrier to rotation about C-C bonds 
is shallow [23]. Because the central methylene group in this recurring motif is readily 
attacked by free radicals [24], polyunsaturated phospholipids are prone to peroxidation and 
αtoc is thought to inhibit the process.  
The amount of αtoc in membranes is extremely small. Reported levels are generally <1 
mol% of the total lipid [25]. Thus, polyunsaturated phospholipid molecules grossly 
outnumber the molecule that is meant to defend them from oxidation by a mechanism 
necessitating intimate contact. How αtoc can effectively do so in an encompassing milieu 
of lipids and proteins is unclear and has led to proposals, as yet unproven, that it 
preferentially interacts with PUFA [9-11]. Atomistic MD simulations have been integral 
in developing a detailed picture of polyunsaturated phospholipid bilayers in which PUFA 
chains rapidly isomerize between conformational states [26-28]. In the current study, we 
applied this computational approach to compare the molecular organization of αtoc in 1-
stearoyl-2-docosahexaenoylphosphatidylcholine (SDPC, 18:0-22-6PC) and 1-stearoyl-2-
oleoylphosphatidylcholine (SOPC, 18:0-18:1PC) bilayers. SDPC with saturated stearic 
acid (SA, 18:0) for the sn-1 chain and DHA for the sn-2 chain is representative of a 
polyunsaturated phospholipid, while SOPC with oleic acid (OA, 18:1) containing a single 
double bond instead for the sn-2 chain serves as a monounsaturated control (Fig. 3.1). Solid 
state 2H NMR and neutron diffraction measurements (done by Drew Marquardt at Chalk 
River Laboratories) were also performed to complement the MD simulations. 
3.2 Materials and methods 
3.2.1 MD simulations  
MD simulations were performed for neat bilayers of SDPC and SOPC and of SDPC and 
SOPC containing 20 mol% αtoc. They were run in the constant particle number, pressure 
and temperature (NPT) ensemble. Each simulation has 100 lipid molecules and 2000 water 
molecules. The initial structures were assembled with the CHARMM-GUI Membrane 
Builder [29,30], and in presence of αtoc were prepared from the lipid-cholesterol structure 
built with CHARMM-GUI by replacing cholesterol with αtoc. Simulations were run using 
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the CHARMM C36 [31] and C36p [32] force fields for SOPC and SDPC, respectively, 
with the customary cut-offs. Non-bonded (pairwise van der Waals and short range 
electrostatic) interactions were smoothly turned off at 10 Å, while the particle-mesh Ewald 
method was employed to calculate long range electrostatic interactions [33]. The 
equilibration of bilayers was achieved using the standard CHARMM-GUI six-step process 
that gradually turns off restraints on lipids over 200 ps [30]. 
Production runs were over a minimum of 200 ns using a time step of 2 fs and the first 20 
ns were considered as equilibration. The simulations were maintained in a rectangular box 
with equal x and y dimension (in the plane of the bilayer) and z varied independently in 
the NPT ensemble. The temperature was kept at 37 °C by the Hoover thermostat [34] while 
the Nosé-Hoover piston was applied to keep the pressure at 1 atm [35]. Analyses of 
simulations included the calculation of order parameters and neutron scattering length 
density (NSLD) profiles. The Lightweight Object-Oriented Structure (LOOS) library was 
employed to construct maps of the lateral distribution of lipid chains relative to αtoc [36]. 
Snapshots of bilayers and plots of the maps of lateral distribution were created with the 
Visual Molecular Dynamics (VMD) program [37]. 
3.2.2 Solid state 2H NMR 
Samples were aqueous multilamellar dispersions of 50 wt% lipid in 50 mM Tris buffer (pH 
7.5). The lipids comprised 1-[2H35]stearoyl-2-docosahexaenoylphosphatidyl-choline 
(SDPC-d35), SDPC-d35/20 mol% αtoc, 1-[2H35]stearoyl-2-oleoylphosphatidyl-choline 
(SOPC-d35) and SOPC-d35/20 mol% αtoc. In each sample there was 25 mg SDPC-d35 or 
SOPC-d35. Avanti Polar Lipids (Alabaster, AL) was the source for the deuterated analogs 
of phospholipids, while deuterium depleted water was purchased from ISOTEC (Sigma-
Aldrich Corporation, St. Louis, MO). αToc was obtained from commercial α-tocopheryl 
acetate by hydrolysis (K2CO3 in methanol for 5 h) and purification of the crude product via 
silica gel column chromatography using a step gradient of hexane:ether (95:5 to 9:1) as the 
eluting solvents. Preparation of the samples was as previously described [38], with 
additional precautions outlined in earlier work taken due to the susceptibility of PUFA to 
oxidation [39]. 
2H NMR spectra were acquired on a homebuilt spectrometer operating at 46.0 MHz with a 
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7.05 T superconducting magnet (Oxford Instruments, Osney Mead, UK) [40] 
implementing a phase alternated quadrupolar echo sequence (90ºx-t-90ºy-acquire-delay)n 
[41]. Data acquisition parameters were 90° pulse width = 3.8 µs; separation between pulses 
t = 50 µs; delay between pulse sequences = 1.0 s; sweep width = ±100 kHz; dataset = 2 K; 
and number of transients = 10,000. The first moment  was calculated from powder 
patterns obtained by conventional FFT and related to an average order parameter  with 
standard equations [42]. The FFT depaking algorithm was applied to produce the 
corresponding aligned spectra characteristic of a planar membrane [43]. Exploiting the 
enhanced resolution of depaked spectra, profiles of order parameter  were then 
constructed assuming the value of  decreases smoothly along a lipid chain from the 
more ordered methylene groups near the membrane surface towards the disordered 
terminal methyl group in the middle of the membrane [44]. 
3.2.3 Neutron diffraction 
Neutron diffraction of aligned multilayers prepared on a silicon single crystal substrate was 
employed to map the density distribution of lipid components along the membrane normal 
(z) direction. The methods have been documented before [12]. The samples were 
comprised of a total of 12 mg of SDPC or SOPC (Avanti Polar Lipids) with 20 mol% αtoc 
or a labeled analog, α-[5-2H3]tocopherol (αtoc-d3), having a deuterated methyl group at the 
5-position on the chromanol group (Fig. 3.1). Preparation of the labeled analog was by a 
previously cited protocol (12). The bilayers were hydrated at fixed humidity using a 
saturated salt solution of KNO3 (94 % RH) with 70, 40, 16, and 8% 2H2O. Care was taken 
throughout sample manipulation and experimentation to minimize exposure to the 
atmosphere and light. Samples were kept at room temperature during initial equilibration 
and controlled at 37±0.5 °C during data collection. 
Diffraction data were taken on the D3 beam-line at the Canadian Neutron Beam Center 
(CNBC, Chalk River, Ontario, Canada). A wavelength of 2.37 Å was selected for the 
neutrons with a single crystal monochromator of pyrolytic graphite. Higher order (i.e., λ/2, 
etc.) reflections were eliminated using a pyrolytic graphite filter. Data correction and 
reconstruction of the bilayer profile proceeded as outlined in earlier work [12]. Briefly, 
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scattering form factors  were obtained from the integrated intensity of each of the quasi-
Bragg peaks, typically 4-8, that were collected. The NSLD profile along the bilayer normal 
 was derived with the cosine transformation of the form factors. The difference between 
the profiles for labeled and unlabeled samples was calculated from the transformation of 
the difference in their respective structure factors. Data were placed on an arbitrary scale 
for comparison with MD simulations. 
3.3 Results 
3.3.1 Membrane organization and structure 
3.3.1.1 Phospholipid acyl chain order 
The order parameter is defined according to 
           (3.1) 
In this equation  is the instantaneous angle between a C-H bond and the bilayer normal, 
about which lipid molecules reorient with axial symmetry, and the angular brackets 
designate a time average [45]. The value of  for a methylene or methyl group in a lipid 
chain is determined by the degree of anisotropy of the motion for the group and the profile 
of order parameter along a lipid chain is a sensitive indicator of membrane organization 
[46]. From the MD simulations performed in the current study we calculated order 
parameter profiles for the sn-1 and -2 chains in SDPC and SOPC both in the absence and 
presence of 20 mol% αtoc. We also determined smoothed order parameter profiles for the 
sn-1 chain from the 2H NMR spectra collected with SDPC-d35 and SOPC-d35. 
Measurements made in 2H NMR experiments are widely employed in validating MD 
simulations [47]. Comparison between the two approaches, however, is not straightforward. 
NMR work is typically, as in this study, conducted at higher water content and in the 
presence of a buffer that can impact bilayer properties [48,49]. Additionally, order 
parameters obtained experimentally are subject to instrumental factors that can distort the 
shape of the spectra from which they are evaluated [50,51].  
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Order parameter profiles along the sn-1 chain derived from MD simulations run on SDPC 
and SOPC bilayers at 37 ºC are plotted in Figure 3.2 (open squares in lower left and right 
panels, respectively). The corresponding surface areas per lipid, together with the values 
in the presence of αtoc, are listed in the Supporting Material (Table S1). In each case, the 
profile has the characteristic shape that is universally seen for a saturated chain esterified 
at the sn-1 position of phospholipids in the lamellar liquid crystalline phase. There is a 
plateau region of largely constant order parameter (  ~ 0.2) in the upper half of the chain 
near the bilayer surface followed by a progressive fall-off in value in the lower half of the 
chain towards the disordered middle of the bilayer [46]. Reflecting the much greater 
disorder possessed by DHA relative to OA in the adjacent sn-2 chain, order parameters are 
10% lower on average in the SA chain of SDPC (  = 0.137±0.003) than SOPC (  = 
0.153±0.003). When 20 mol% αtoc is added, the response is to increase order while 
maintaining the same overall shape for the profile along the SA chain in both SDPC (  
= 0.010) and SOPC (  = 0.008) (open squares in upper left and right panels, 
respectively, in Fig. 2). This behavior is consistent with results published in earlier 2H 
NMR studies on saturated and monounsaturated PC systems [38,52,53]. The condensing 
effect of αtoc is, not surprisingly, more modest than seen with cholesterol [54,55]. 
Although both molecules are comprised of rigid rings with a hydroxyl group at one end 
and a branched chain at the other, the chromanol group on αtoc is about half the size of the 
steroid moiety on cholesterol. 
The general trends seen in the profiles calculated from the MD simulations are corroborated 
by the order parameter profiles along the sn-1 chain constructed from 2H NMR spectra 
collected using SDPC-d35 and SOPC-d35 (continuous line in the left and right panels, 
respectively) that are included in Figure 3.2. SDPC-d35 (  = 0.130±0.003) is appreciably 
more disordered than SOPC-d35 (  = 0.143±0.003), and adding αtoc increases order in 
SDPC-d35 (  = 0.011) and SOPC-d35 (  = 0.015). Because the profiles generated 
by NMR data are smoothed, it should be noted that subtleties in variation within the plateau 
region are not discerned. Copies of the depaked spectra from which the profiles were 
obtained can be found in Figure A1.1 in the Supporting Material. 
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Order parameters calculated from the MD simulations along the sn-2 chain of SDPC and 
SOPC are shown in Figure 3.3. In agreement with results from experiment [56], order 
parameters throughout almost all of the DHA chain in SDPC are very small (  < 0.05) 
due to the high degree of flexibility associated with the multiple double bonds (open circles 
in left panel, Fig. 3). The  values are comparable to the lowermost disordered portion 
of the SA chain at the sn-1 position. The profile for the OA chain in SOPC, by contrast, 
resembles that for the SA chain except there is a precipitous dip in the value of  in the 
vicinity of the double bond (open circles in right panel, Fig. 3). Such a discontinuity is a 
feature of the order parameters obtained for an OA chain in phospholipid bilayers from 2H 
NMR spectra [57] and computer simulations [58]. A most probable orientation that results 
in intrinsically low  values, not local segmental motion of large amplitude, is 
responsible [57,59]. Deviation from monotonic variation for the order parameter is evident, 
as well, at the C2 position where the values of  for the two C-H bonds on the methylene 
group are depressed and unequal. It is attributed to constraints imposed by the glycerol 
backbone upon the initial orientation of the sn-2 chain [60].  
 An increase that is barely perceptible is revealed by the order parameters presented for the 
DHA chain in SDPC upon the introduction of 20 mol% αtoc in Figure 3.3 (crosses in left 
panel). The change in average value determined for order parameter (  = 0.004) is 
correspondingly very small. Minimal interference with the rapid transition between 
torsional states adopted by the polyunsaturated sn-2 chain due to αtoc is implied. Among 
the myriad of conformations formed, as identified in pioneering MD simulations on DHA-
containing phospholipids [61], are bent arrangements that bring much of the chain up to 
the membrane surface. How the OA chain in SOPC is affected by the addition of αtoc has 
more in common with the situation for the SA chain. Like the SA chain, order parameters 
in the OA chain are elevated (  = 0.013) in a profile that retains the shape observed in 
the absence of αtoc (crosses) in right panel, Fig. 3). 
3.3.1.2 Location of α-tocopherol 
Figure 3.4 displays NSLD profiles for SDPC (left) and SOPC (right) bilayers containing 
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20 mol% αtoc computed from our MD simulations (upper panel). By assigning a neutron 
scattering length to each atom, they were generated with 
         (3.2) 
Here  is the distance from the center of the membrane,  is the neutron scattering length 
for an atom of type  and  is the number of atoms of type  in slices that are 0.2 Å 
thick. This format reveals structural information in a manner that is directly comparable to 
experiment. The distribution of the atoms on all the lipids (phospholipid and αtoc) about 
the midpoint of the bilayer ( ) has a negative dip at the middle that is due to the 
disordered methyl groups at the end of the lipid chains (dashed line). Scattering from the 
phosphate and glycero-ester regions is responsible for the symmetrically located maxima 
on each side. The separation of these maxima roughly represents the hydrocarbon thickness 
of the bilayer [62], which is 34.1±0.3 Å for SDPC (left upper panel) and 35.6±0.4 Å for 
SOPC (right upper panel). Consistent with the larger cross-sectional molecular area that 
accompanies higher disorder (Table S1 in Supporting Material), the bilayer is thinner for 
SDPC than SOPC. The scattering profile for only the deuterons, isotopic substituting for 
hydrogen, on the methyl group at the C5 position of the chromanol group in αtoc consists 
of a pair of peaks (continuous line). The peaks are ±13.7 and ±14.0 Å from the center of 
the bilayer in SDPC and SOPC, respectively. They are ~3-4 Å (3.3±0.4 Å in SDPC and 
3.8±0.5 Å in SOPC) inside the maxima due to all atoms on the lipids in each case, which 
situates the chromanol group just below the membrane surface in SDPC and SOPC and is 
consistent with hydrogen bonding to the carbonyl groups on the phospholipids. This 
location falls within a range of sites in the vicinity of the aqueous interface that has been 
identified for a number of phospholipids by a variety of experimental techniques as well as 
computer modeling [12,13,25,63].  
The MD simulations reproduce the chief features of the results from neutron diffraction 
measurements on aligned multilayers of SDPC (left, lower panel) and SOPC (right, lower 
panel) with 20 mol% αtoc that are also reported in Figure 3.4. That a reduced level of 
hydration applies to the experiments (~11-15 water molecules/lipid) relative to the 
simulations (~20 water molecules/lipid) should be borne in mind. A separation of 35.0±1.6 
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Å in SDPC and 38.8±0.2 Å in SOPC applies to the maxima that flank the negative dip at 
the center of the NSLD profiles for the whole bilayer (dashed line) obtained by analyzing 
the neutron diffraction peaks (Fig. A1.3 in Supporting Material). In these profiles the 
contribution from water was suppressed by conducting the experiments with water that 
contained 8% 2H2O [62]. The pair of peaks identified from the difference between NSLD 
profiles evaluated with bilayers prepared with labeled (αtoc-5d3) and unlabeled αtoc (Fig. 
A1.4 and Table S2 in Supplementary Material), places the C5 position on αtoc at ±19.0 
and ±21.0 Å with respect to the center of the bilayer in SDPC and SOPC, respectively 
(continuous line). They lay ~2 Å (1.5±2.0 Å in SDPC and 1.6±1.0 Å in SOPC) outside the 
maxima due to the entire lipid in both cases, such that the chromanol group slightly 
protrudes into the phospholipid head group region which suggests that there is hydrogen 
bonding to the phosphate group. Like the data from the MD simulations, although 
differences in detail exist, the experimental observations confirm that the chromanol group 
resides near the aqueous surface in SDPC and SOPC and imply that there is no appreciable 
disparity between the depth of αtoc in the polyunsaturated and monounsaturated systems. 
The reason for the apparent discrepancy in position within the bilayer determined for αtoc 
from the analyses of our computational and experimental results is not entirely evident. 
Both approaches have inherent limitations, in common with NMR and other methods, and 
probe a system under conditions that are not identical. The MD simulations, the accuracy 
of which fundamentally depends on the reliability of the force field employed, were run on 
a patch containing 100 lipid molecules in a single bilayer. The neutron diffraction 
experiments, which rely crucially on the precise scaling of measurements made on two 
independent samples that differ only in isotopic replacement of deuterium for hydrogen at 
a specific molecular site, were performed on aligned multilayers on a silicon crystal 
substrate prepared, as noted above, at lower hydration. Exactly where αtoc sits, moreover, 
cannot be surmised from the literature that has been published to date. Three basic models, 
which were comprehensively discussed in a subsequent review [25], have been proposed 
[64]. They have the chromanol group poking into the head group region, recessed within 
the interfacial region and submerged into the bilayer. Each one has experimental support 
[25]. The majority of the earlier reports, albeit often somewhat qualitative and/or subject 
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to perturbation problems associated with the use of an extrinsic probe molecule, favor the 
latter two models. A location at the surface or within the bilayer was concluded on the basis 
of the quenching of the intrinsic fluorescence of αtoc produced by nitroxyl or anthroyloxyl 
stearic acids incorporated into 1,2-dipalmotoylphosphatidylcholine (DPPC, 16:0-16:0PC) 
and egg phosphatidylcholine (PC) vesicles [65,66], the time course of the loss in intensity 
for 19F NMR signals from 19F-labeled analogs of αtoc in egg PC vesicles following the 
addition of Pr3+ [67] and the chemical shift-polarity correlation of 13C NMR resonances for 
αtoc in 1,2-dimyristoylphsphatidylchholine (DMPC, 14:0-14:0PC) vesicles [68]. Close to 
the phosphate, the dissenting view that has the chromanol group in the polar region of the 
phospholipid head groups, was deduced from lanthanide induced shifts of 13C NMR spectra 
observed for a 13C-enriched analog of αtoc in egg PC vesicles [69]. 
Although providing more quantitative information, the MD simulations and neutron 
scattering work that have been described more recently only compound the debate. Like in 
the current investigation, the tendency is for the respective methods to place the chromanol 
group on opposite sides of the lipid-water interface. Just beneath the interface was indicated 
in the computer simulations conducted on saturated and monounsaturated 
phosphatidylcholine (PC) bilayers [63,70]. Above and within the interfacial region was 
found in the neutron diffraction experiments done on saturated, monounsaturated and 
polyunsaturated PC multilayers [12], although a dependence upon head group causing 
deeper penetration in 1-palmitoyl-2-oleoylphosphatidylserine (POPS) was observed as 
well [13]. That quite different water contents were employed should again be recognized 
when comparing the two types of result. It is impossible, additionally, to discern a pattern 
in the variation in placement determined for the chromanol group by the neutron scattering 
measurements. As an example, substantially above vs. slightly below the lipid-water 
interface was seen in 1-palmitoyl-2-oleoylphosphatidylcholine (POPC, 16:0-18:1PC) and 
1,2-dioleoylphosphatidylcholine (DOPC, 18:1-18:1PC), which is the reverse of the trend 
seen in 1-palmitoyl-2-arachidonylphosphatidylcholine (PAPC, 16:0-20:4PC) and its more 
disordered, homo-acid counterpart 1,2-diarachidonylphosphatidylcholine (DAPC, 20:4-
20:4PC) [12]. Neutron scattering data that has also been reported showing αtoc sequesters 
at the center of DMPC bilayers further illustrate how poorly the situation is understood  
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[38]. A systematic attack on this problem will clearly be necessary in the future to resolve 
the issue. 
 
3.3.2 Interaction of α-tocopherol with phospholipid acyl chains 
To probe the relative affinity of αtoc for SDPC vs. SOPC, the van der Waals (vdW) 
interaction energy between αtoc and phospholipid acyl chains and the density of each chain 
surrounding αtoc molecules were determined from the MD simulations. 
3.3.2.1 van der Waals interaction energy 
The vdW interaction energy was calculated in CHARMM by summing over pairs of non-
bonded atoms using the standard Lennard-Jones potential 
          (3.3)  
where  and are the energy and separation between pairs of atoms  at equilibrium, 
respectively, and  is the distance between the atoms [31]. Figure 3.5 shows the results 
for αtoc in SDPC (upper) and SOPC (lower) in the form of a bar graph. Separate values of 
 describing the interaction with the sn-1 and -2 chains are plotted. They reveal that 
the vdW interaction energy of αtoc with the saturated SA chain at the sn-1 position is less 
in SDPC (-20.3 kcal/mol) than SOPC (-23.4 kcal/mol), which we ascribe to the enhanced 
disorder, and hence loose packing, within the polyunsaturated bilayer. The opposite 
situation applies to the interaction of αtoc with the unsaturated chains at the sn-2 position. 
The vdW energy for the DHA chain in SDPC (23.2 kcal/mol) exceeds that for the OA chain 
in SOPC (21.4 kcal/mol). Moreover, the value of  for DHA is larger than SA in SDPC 
whereas it is smaller for OA than SA in SOPC. We attribute the greater proximity to αtoc 
implied for the polyunsaturated chain, paradoxically, to the tremendously high 
conformational freedom it possesses compared to a monounsaturated chain. Maps of the 
density of each chain around αtoc molecules constructed from the simulations provide 
insight into our explanation. 
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3.3.2.2 Spatial distribution of sn-1 and -2 chains 
To better understand the interaction with the different chains in SDPC and SOPC, maps of 
the density of carbon atoms on the sn-1 and -2 chains surrounding αtoc molecules were 
generated utilizing the LOOS analysis library [36]. In our examination the rigid chromanol 
group serves as the molecular frame of reference and a vector extending from positions 
C4-6 specifies the orientation relative to the bilayer normal. The population distributions 
for this vector calculated from our simulations possess a maximum, representing the most 
probable orientation, at 39° in SDPC and 35.5° in SOPC. A state for an αtoc molecule 
closely matching the most probable orientation in a bilayer was then selected from our 
simulations and for each αtoc molecule in every frame of trajectory, the entire system was 
translated and rotated so that all of the chromanol groups were aligned with this reference. 
Next, summing over the realigned trajectories, we mapped the probability density for the 
sn-1 and -2 chains of either SDPC or SOPC separately within a cube of  Å3 
lying in the plane of the bilayer in the reference system with an origin at the center of mass 
of the chromanol group. The cube was divided into  Å3 bins, and the probability 
density  is proportional to the number of times the carbon atoms in each chain appear in 
a bin during the 180 ns of simulation time.  
In Figure 3.6, the difference in spatial distribution of the sn-1 and -2 chains in SDPC (left 
column) and SOPC (right column) relative to αtoc is explored. For this purpose we have 
defined the parameter  
          (3.4) 
where the subscripts specify the probability density for the respective chains. Two slices 
separated by about 10 Å in depth coinciding with the chromanol group (slice A) and well 
below within the phytyl side chain (slice B) are shown. They are color-coded contour maps 
in which Δ𝜌 > 0 indicates a higher probability density for the sn-2 chain whereas Δ𝜌 < 0 
indicates a higher probability density for the sn-1 chain. There is a small central region 
where Δ𝜌 = 0 that corresponds to the location of the chromanol group in slice A. Such a 
region is absent in slice B which does not intersect with the chromanol group. In the case 
of SDPC, it is clear from slice A that around the chromanol group the probability of finding 
DHA (sn-2 chain) substantially exceeds SA (sn-1 chain). Lower down in the bilayer at slice 
303030 ××
111 ××
ρ
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B, the probability of more DHA than SA is no longer found and a largely uniform 
probability distribution exists across the entire slice. The situation differs in SOPC. Only a 
small differential exists between the probability of finding OA (sn-2 chain) and SA (sn-1 
chain) around the chromanol group in slice A. In slice B, there is more SA than OA 
throughout. 
The higher probability that DHA will be near the chromanol group can be explained in 
terms of the tremendous flexibility of the polyunsaturated chain, which leads to very low 
order parameters (  < 0.05) throughout the entire DHA chain that are minimally 
perturbed by the presence of αtoc in SDPC (Fig. 3.3). With the exception of the very top 
portion, the DHA chain in SDPC moves through all conformational space in 50 ns [71]. A 
greater density for DHA near the membrane surface, as opposed to the more rigid SA chain 
that has greater density in the middle of the membrane, is the result [72]. This arrangement 
ensures that all parts of the DHA chain frequently approach the hydroxyl group on the 
chromanol group that is responsible for the antioxidant function of αtoc. 
3.3.3 Flip-flop of α-tocopherol 
Figure 3.7 uncovers another aspect of the behavior of αtoc in a polyunsaturated 
environment with potential significance for the role of vitamin E as an antioxidant. In this 
figure the trajectory in the transbilayer (z) direction for the C5 position on the chromanol 
group of one of the αtoc molecules in the SDPC bilayer is plotted over 60 ns of simulation. 
The plot demonstrates that, although the chromanol group usually sits at its canonical depth 
near the aqueous interface, the αtoc molecule also undergoes flip-flop across the bilayer. 
At around 50 ns the C5 position jumps from one side of the bilayer to the other and 
subsequently back at around 75 ns. The “jumps” are abrupt, ~5 ns in duration. During them, 
as illustrated in 3 snapshots taken during the first “jump” (Fig. 7), the αtoc molecule adopts 
short-lived conformations that include lying in the middle of the bilayer approximately 
parallel to the plane. A total of 22 flip-flops were counted throughout 180 ns for all 20 αtoc 
molecules in the bilayer, from which a lifetime of 0.16 µs (equivalent to half-life t1 2  = 0.11 
µs) in SDPC was estimated. This rate is  faster than in SOPC where only 2 flip- 
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flops of αtoc molecules, corresponding to a lifetime of 1.8 µs ( t1 2  = 1.2 µs), transpired 
under the same circumstances.  
Flip-flop of phospholipids across protein-free membranes has long been recognized to be 
extremely slow [73]. Passage through the hydrophobic interior is energetically unfavorable 
for the hydrophilic head groups. A timescale of hours applies to the half-lives that have 
been measured by a variety of techniques, with the values depending upon head group and 
chain composition [74,75]. Half-lives of 0.29 and 11.5 h describe the flip-flop of 
fluorescently labeled 7-nitrobenz-2-oxa-1,3-diazol-4-yl phosphatidylethanolamine in 
SDPC and SOPC bilayers, respectively, at 25 °C [75]. They represent an increase in rate 
by a factor of 40×  for the polyunsaturated membrane. 
Very little attention has been paid to the flip-flop of αtoc. Estimates of the rate have been 
gleaned from only a sparse collection of MD simulations and experiments. There is an 
enormous discrepancy in the literature between the values according to these two 
approaches. Like in the current work, translocation of αtoc from one leaflet to the other 
was observed in recently published simulations run for ~200 ns on several phospholipid 
bilayers in a highly fluid state at 350 K [63,70]. A timescale of hours or longer, quite the 
reverse, was inferred in experimental studies conducted 3 decades ago monitoring the 
exchange of αtoc between the inner and outer layers of sonicated unilamellar vesicles (SUV) 
[76,77]. In our hands, however, assays of the oxidation of αtoc in PC vesicles showed 
complete loss of a fluorescence signal from αtoc on both sides of the bilayer in only a few 
minutes following the addition of potassium ferricyanide (unpublished data). There was no 
hint of long-term rate limitation brought about by flip-flop from the inner to outer leaflet. 
The very slow speed of transmembrane migration indicated for αtoc by the early work is 
difficult to understand. Methyl groups on either side (positions 5 and 7) shield the hydroxyl 
group in the chromanol moiety (Fig. 1), which should help overcome the energy barrier to 
movement through the hydrophobic core of the membrane. MD simulations on δ-
tocopherol (δtoc), where neither position next to the hydroxyl group is methylated, in 
SDPC support this notion. There were only 2 flip-flops over 180 ns for δtoc in simulations 
that we ran under conditions identical to those on αtoc. Why flip-flop of αtoc should be 
much slower than cholesterol for which seconds characterize the process [78] is also a 
57 
 
 
mystery. Both molecules are structurally similar, composed of a rigid head group 
possessing a hydroxyl group at one end and a branched hydrocarbon chain at the opposite 
end. 
3.4 Discussion 
αToc is the form of vitamin E that is a required component in the human diet. The primary 
function of this lipophilic antioxidant is to protect lipids, especially polyunsaturated 
phospholipids, in membranes against oxidation [79,80]. To accomplish this purpose it traps 
a lipid peroxyl radical to break a chain of reactions that once initiated can oxidize many 
lipid molecules, and is subsequently restored by a water-soluble reducing agent such as 
ascorbate. Here we have, for the first time, performed atomistic MD simulations on the 
molecular organization of αtoc in a polyunsaturated phospholipid membrane. SDPC and 
SOPC bilayers in the absence and presence of 20 mol% αtoc were compared. SDPC is a 
polyunsaturated phospholipid that is representative of lipid species most susceptible to 
oxidative attack, while SOPC serves as a monounsaturated control that is much less 
vulnerable to such an assault. 
The simulations capture the essence of the results from solid state 2H NMR and neutron 
diffraction experiments that were carried out to provide validation. The same distinctive 
shape defines the variation of order parameter along the SA chain at the sn-1 position in 
SDPC and SOPC obtained from the simulations and by analysis of 2H NMR spectra (Fig. 
2). There is a plateau region of essentially uniform order in the upper portion of the chain 
and then in the lower portion order drops off progressively more quickly towards the 
terminal methyl group. In line with the NMR derived data, the profiles generated in silico 
demonstrated that SDPC is much more disordered than SOPC while the introduction of 
αtoc increases order by comparable amounts in both SDPC and SOPC. In accordance with 
the neutron diffraction measurements, the location of maxima attributable to the phosphate 
and glycerol-ester regions in the NSLD profile calculated from MD simulations showed 
that the thickness of the bilayer for SDPC is smaller than SOPC (Fig. 4). Both methods 
also placed the C5 position on the chromanol group of αtoc near the aqueous interface in 
the two membranes. 
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By comparing SDPC and SOPC bilayers, our simulations reveal aspects of molecular 
organization that help αtoc prevent the oxidation of polyunsaturated phospholipids. The 
extraordinary disorder possessed by PUFA chains, which promotes contact with the 
sacrificial hydroxyl group on the chromanol moiety, is key. The extremely low order 
parameters that characterize the profile of order along the DHA chain at the sn-2 position 
in SDPC (Fig. 3) are indicative of a rapidly varying conformation that redistributes the 
lower portion towards the bilayer surface [72,81]. There is consequently, as depicted in 
maps of acyl chain density generated from the simulated data (Fig. 6), increased likelihood 
that polyunsaturated chains reside in the immediate vicinity of the chomanol group on αtoc 
molecules. It is also apparent from plots of trajectories in the transbilayer direction that 
αtoc flip-flops across the bilayer in SDPC on a sub-microsecond timescale (Fig. 7), which 
is >10x more often than seen in SOPC. The frequent tunneling of αtoc through the fluid 
interior of an SDPC bilayer further enhances the chance that a chromanol group meets a 
polyunsaturated chain. 
The findings from the MD simulations presented in this study, taken together, provide 
unprecedented structural insight into the molecular mechanism by which αtoc can 
efficiently inhibit the oxidation of polyunsaturated phospholipids in a membrane. They 
demonstrate how the hydroxyl group on the chromanol moiety, the reducing group in αtoc, 
is readily accessible to a lipophilic peroxyl radical formed anywhere within a PUFA chain 
and to water-soluble radicals that are necessary to restore antioxidant activity. The majority 
of the time the chromanol group sits near the membrane surface where water-soluble 
radicals easily reach it and intrinsic disorder brings even the lowest portion of 
polyunsaturated chains into close proximity on a regular basis. Flip-flop of αtoc, in addition, 
carries the chromanol group into the membrane interior and then back to the surface. This 
motion is made easier by loosely packed PUFA chains and by methyl groups at adjacent 
positions on the chromanol moiety that screen the hydroxyl group from the hydrophobic 
environment within a bilayer. It is emphasized that αtoc does not directly protect PUFA, 
but instead interacts with free radical intermediates formed during the series of reactions 
by which peroxidation proceeds. Our interpretation assumes that oxidized lipid chains 
retain high conformational mobility, which is implied by earlier work [82]. The situation 
is obviously more complex in a biological membrane. Because the concentration of αtoc is 
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small, typically in the range 0.1-1.0 mol% total phospholipid [25], lateral distribution 
relative to polyunsaturated phospholipids is another issue that affects its efficacy as an 
antioxidant. We have postulated that αtoc clusters together with polyunsaturated 
phospholipids in domains, thereby locally compensating for its overall scarcity (11,16). 
This arrangement would facilitate frequent encounters with lipid peroxyl radicals by the 
mechanisms identified here. 
In summary, an understanding of the role molecular structure plays in αtoc stopping the 
oxidation of polyunsaturated phospholipids in membranes emerges from our MD 
simulations. The simulations on SDPC show that the chromanol group lies in wait to meet 
DHA chains that move up to the surface of the bilayer and, remarkably, travels down into 
the inside of the bilayer as well. Thus, mechanisms by which αtoc not only can intercept 
lipid peroxyl radicals at the surface of a membrane but can also patrol the inside of the 
membrane are identified. By predominantly sitting with the chromanol group near the 
membrane surface, moreover, access to water soluble reducing agents that recycle α-
tocopheroxyl radicals formed when lipid peroxyl radicals are trapped is assured. We 
conclude from our results that αtoc is a lipid-soluble antioxidant that is well designed to 
protect polyunsaturated phospholipids in cell membranes. 
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Figure 3.1 
Molecular structure of αtoc, SDPC and SOPC. 
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Figure 3.2 
Order parameter profiles along the sn-1 chain in SDPC and SOPC at 37 ºC obtained from 
MD simulations (□) and FFT depaked 2H NMR spectra (continuous line). The lower left 
panel is for SDPC and the upper left panel is for SDPC + 20 mol% αtoc, while the lower 
right panel is for SOPC and the upper right panel is for SOPC + 20 mol% αtoc. Figure A1.2 
included in the Supporting Material shows the effect of αtoc on the order parameter profiles 
obtained from the MD simulations and 2H NMR experiments separately. The uncertainty 
in the simulated data is ≤±2%, which was estimated from the standard error obtained 
treating each lipid molecule independently. A reproducibility of ±2% applies to the NMR 
data. 
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Figure 3.3 
Order parameter profiles along the sn-2 chain in SDPC and SOPC at 37 ºC obtained from 
MD simulations. The left panel is for SDPC (○) and SDPC + 20 mol% αtoc (x), while the 
right panel is for SOPC (○) and SOPC + 20 mol% αtoc (x). 
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Figure 3.4 
Neutron scattering length density (NSLD) profiles for SDPC+ 20 mol% αtoc (left) and 
SOPC + 20 mol% αtoc (right) at 37 ºC obtained from MD simulations (upper panel) and 
neutron diffraction experiments (lower panel). The dashed line is the profile for all lipids 
(phospholipid and αtoc), while the solid line is the profile for deuterium on the C5 position 
of the chromanol group in αtoc (amplified in intensity for comparison). The uncertainty in 
the location of the center of the peak for the C5 position is ±0.3 Å in SDPC and SOPC 
(MD simulations), and ±1.5 Å in SDPC and ±1.0 Å in SOPC (neutron diffraction 
experiments). 
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Figure 3.5 
van de Waals (vdW) energy for the interaction of αtoc with the sn-1 chain (clear bar) and 
sn-2 chain (grey bar) of the phospholipid in SDPC + 20 mol% αtoc (upper panel) and SOPC 
+ 20 mol% αtoc (lower panel). The values plotted are an average over time for all αtoc 
molecules, and the errors were calculated based on the values for each αtoc molecule. 
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Figure 3.6 
Color-coded contour maps of the difference in probability density (∆𝜌 = 𝜌& − 𝜌%) for the 
carbons on the sn-1 and -2 chains in SDPC and SOPC around αtoc. The unit for ρ is the 
number of carbons counted in 1×1×1 Å3 bins over 180 ns of simulation. The densities 
were generated in a 30×30×30 Å3 cube centered on αtoc. Two representative slices lying 
in the xy plane (parallel to membrane surface) at different depth are shown. Slice A 
intersects the chromanol group while slice B lays approximately 10 Å below. To place the 
scales for Δ𝜌 in context the respective average values for 𝜌% and 𝜌& in slice A are 3.95 and 
5.15 for SDPC and 3.97 and 4.35 for SOPC, and in slice B and are 4.74 and 4.79 for SDPC 
and 4.97 and 4.01 for SOPC. 
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Figure 3.7 
Trajectory in the transbilayer (z) direction of a representative αtoc molecule (continuous 
line indicates depth of C5 position on chromanol group) in SDPC (dashed line signifies 
location of glycerol backbone). Flip-flop of αtoc back and forth across the bilayer occurs 
at 50 and 75 ns. The 3 snapshots illustrate how the flip-flop occurs in short time (~5 ns). 
An enlarged version of the snapshots may be found in the Supporting Material (Fig. A1.5). 
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CHAPTER 4. BINDING OF VITAMIN E TO LIPID BILAYERS: 
UMBRELLA SAMPLING MD SIMULATIONS 
4.1 Introduction 
Vitamin E stands for the name of a group of naturally occurring, biologically active tocol 
(tocopherol and tocotrienol) compounds [1,2]. α-Tocopherol (αtoc) is the form that is 
retained in the human body. This lipid soluble antioxidant is an essential micronutrient, 
neurological problems being among the symptoms of its deficiency [3]. There is general 
agreement that the primary function for αtoc is to protect polyunsaturated lipids that are 
extremely susceptible to attack from free radicals in membranes [2,4-6]. The growing 
consumption of fish oil supplements rich in omega-3 polyunsaturated fatty acids (n-3 
PUFA) that are taken up into membrane phospholipids underscores the importance of this 
role [7-9]. Although the chemistry by which αtoc inhibits the peroxidation of lipid chains 
is known [10.11], an open question is whether preferential interaction with polyunsaturated 
lipids exists [12-14].  
The αtoc molecule is composed of a chromanol head group with a hydroxyl group at one 
end and a phytyl chain at the other end (Figure 4.1). It usually resides in a membrane with 
the hydroxyl group near the aqueous interface while the phytyl chain extends towards the 
center [15, 16]. In this arrangement the sacrificial hydroxyl group traps lipid peroxyl 
radicals when they rise up to the surface of the membrane and subsequently is recycled by 
a water-soluble reducing agent such as ascorbate [17]. The general features of the location 
and orientation of αtoc in phospholipid bilayers are reproduced in the few atomistic MD 
simulations that have been published to date [18-20]. Our simulations demonstrated how 
efficiently αtoc is able to fulfill its antioxidant role in a polyunsaturated phospholipid 
bilayer [20]. They revealed that high disorder enhances the probability that a 
polyunsaturated chain comes into close proximity with the hydroxyl group on a chromanol 
group that resides at the surface of the bilayer. Additionally, we observed flip-flop for αtoc 
is fast, which suggests the hydroxyl group can also easily penetrate into the interior of a 
polyunsaturated membrane to intercept lipid peroxyl radicals. 
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Here we follow up on our earlier simulations with an umbrella sampling molecular 
dynamics (USMD) simulation study that compares the binding of αtoc to 1-stearoyl-2-
docosahexaenoylphosphatidylcholine (SDPC, 18:0-22-6PC) and 1-stearoyl-2-
oleoylphosphatidylcholine (SOPC, 18:0-18:1PC) bilayers. The molecular structure of 
SDPC with saturated stearic acid (SA, 18:0) for the sn-1 chain and docosahexaenoic acid 
(DHA, 22:6) containing 6 double bonds for the sn-2 chain is representative of a 
polyunsaturated phospholipid. SOPC where the sn-2 chain is replaced by oleic acid (OA, 
18:1) that has a single double bond serves as a monounsaturated control (Figure 4.1). Does 
αtoc have a preference for polyunsaturated phospholipids, as has been hypothesized 
[12,14], is the question that we address. 
4.2 Methods 
4.2.1 MD simulations 
We prepared two lipid membrane systems: SDPC with αtoc and SOPC with αtoc. In each 
case there are in total 80 PC lipid molecules and 2 αtoc molecules, which are divided 
equally between the two leaflets. The initial structures of these lipid bilayers were taken 
from our earlier published simulations containing 20 mol% αtoc, which have been 
equilibrated and run for over 200 ns [20]. We deleted the extra αtoc molecules, leaving two 
of them - one in each leaflet - to get the bilayer content we needed. In order to ensure 
enough room to allow an αtoc molecule to be fully pulled out of the bilayer into the aqueous 
phase, the bilayers were hydrated with 8562 water molecules that made a water layer of 
approximately 45 Å on each side. A harmonic constraint was applied to the two αtoc 
molecules to keep them 35 Å apart in the xy plane, which is approximately ½ the diagonal 
length of the bilayer, to minimize interactions between them during the umbrella sampling 
process. We used the CHARMM C36p force field for all simulations [21]. Non-bonded 
(van der Waals and short-range electrostatic) interactions were gradually switched off at 
10 Å, and the long-range electrostatic interactions were calculated using the particle-mesh 
Ewald method [22]. Periodic boundary conditions were applied to a rectangular box in 
which the x and y dimensions (in the plane of the membrane) were held equal while the z 
dimension (in the direction of the membrane normal) was varied independently. The 
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temperature was kept at 37 °C by the Hoover thermostat [23] and the Langevin piston 
method was applied to maintain the pressure at 1 atm [24]. 
4.2.2 Umbrella sampling 
With USMD simulations we obtained the free energy, known as the potential of mean force 
(PMF), as a function of αtoc’s distance from the bilayer center. Then the energy cost of 
pulling an αtoc molecule out from the bilayer, which we call the binding energy, was 
determined from the corresponding PMF profile. The procedure was briefly as follows. 
The distance along the direction (z) of the membrane normal between the center of the 
bilayer and the center of mass of the rigid chromanol headgroup on each αtoc molecule 
was chosen to represent the location of αtoc - the reaction coordinate. The αtoc molecules 
in both leaflets were restrained symmetrically with respect to the center of bilayer, which 
maintains the compositional balance of the bilayer and doubles the sampling efficiency. 45 
windows i were simulated with the value of zi varying from 0 to 44 Å in increments of 1 
Å. In each window i, the αtoc molecules were restrained by a harmonic potential 
                                                        𝑈E = 𝑘(𝑧 − 𝑧E)&                                                  (4.1) 
with a force constant k = 3.68 kcal/(mol·m2) at the corresponding zi value. The initial 
structures in the windows were generated by a series of simulations that pulled the αtoc 
molecules from the equilibrium position to z = 0 Å or z = 44 Å with a speed of 1 Å/ns. The 
replica exchange method was applied during umbrella sampling to optimize the process. 
Production runs were performed with NAMD [25] on the Big Red II super computer at 
Indiana University. Their duration was 200 ns in each window, with the last 100 ns of the 
trajectories employed to perform the PMF calculation using the weighted histogram 
analysis method (WHAM) [26]. Errors were estimated following a method that has been 
previously described [26]. 
4.3 Results 
4.3.1 Potential of mean force 
Figure 4.2 shows the PMF (G(z)) vs. position relative to the center of the bilayer calculated 
from our simulations for αtoc in SDPC and SOPC. As expected, the shape of the plots 
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resembles that reported for cholesterol [27] - like αtoc, the sterol consists of a rigid moiety 
(tetracyclic ring) with a hydroxyl group at one end and a branched chain at the opposite 
end [14]. The variation of G(z) is flat where αtoc becomes completely disengaged from the 
membrane (z ≥ 35 Å) in the water, and the baseline (G=0) is set there. When αtoc is brought 
into contact with phospholipid, G(z) starts to drop as αtoc penetrates more deeply within 
the membrane until the equilibrium location is reached (where G(z) = G(zeq) exhibits a 
minimum). Then there is small increase in G(z) towards the center of the bilayer (z=0) that 
represents a barrier to movement from one side of the bilayer to the other. We define the 
binding energy of αtoc in the membrane to be ΔGbind = -G(zeqG 0 -Gghi) and the free 
energy barrier for the flip-flop of αtoc between leaflets to be ΔGflip = G(0) - 
G(zeqG 0 -Gghi). Table 4.1 lists the magnitude of these quantities for SOPC and SDPC. 
Also included in the table are values for the equilibrium depth zeq of αtoc in the two bilayers 
(10.1 Å in SDPC and 11.4 Å in SOPC), which qualitatively agree with estimates made 
from our previous standard all-atom MD simulations (11.3 Å in SDPC and 11.8 Å in SOPC) 
[20]. Exact agreement is not be expected in view of the increase in bilayer order and 
thickness that accompanies the higher concentration of the vitamin in the earlier work (20 
vs. 2.5 mol%). 
4.3.2 Binding energy 
The binding energy ΔGbind evaluated here for αtoc by UBSMD simulations in SDPC (16.7 
kcal/mol) is lower than in SOPC (18.3 kcal/mol) (Table 4.1). From the plots of PMF (Fig. 
4.2), we can see that the differential originates in the interfacial region (z ≈ 35 Å) where 
αtoc starts to interact with the membrane. An abrupt change in the slope of the PMF curve 
occurs there in SOPC, from flat when αtoc is entirely in the aqueous phase to an 
approximately linear decline as the phytyl sidechain and then the chromanol group 
penetrate more deeply into the bilayer. In SDPC, the change in slope of the PMF curve is 
initially more gradual (31 £ z £ 35 Å) and only subsequently at greater depth within the 
bilayer does the curve become approximately linear in slope. We attribute this behavior to 
the more loosely packed nature of the polyunsaturated bilayer. The PMF curve in SDPC 
consequently lies a bit above that in SOPC, resulting in a correspondingly smaller binding 
energy. 
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4.3.3 Membrane deformation 
Insight into the effect of desorption of αtoc on membrane structure may be gleaned from 
inspection of the simulations obtained during umbrella sampling. Deformation of the 
SDPC and SOPC membrane is observed in the windows where αtoc has been partly pulled 
out from the membrane. Figure 4.3A shows this deformation as a plot of z(r), which is the 
average z coordinate (relative to the center of then bilayer) of the phosphorus atoms located 
on the PC head groups, against their lateral distance from αtoc in different windows – i.e. 
held at different depths in the membrane. The curves are mostly flat from window 0, where 
the αtoc molecule is at the middle of the bilayer, to widow 10, which is its equilibrium 
position. For windows 20 and 30, when αtoc is in the interfacial region, nearby (r ≤ 15 Å) 
there is an increase in z(r). This indicates the head groups on the lipids located near αtoc 
extend into water more than on ones farther away - in other words, the pulling of αtoc out 
of the bilayer deforms the membrane. The snapshot presented in Figure 4.3B gives an 
illustration of the deformation. Once αtoc is completely in water, the membrane returns to 
normal as shown in window 35 where no deformation is apparent. We take the difference 
in z(r) between the window (r = 5 Å) where it is greatest in magnitude and where αtoc is at 
its equilibrium depth as a measure of how much the membrane is deformed when αtoc is 
removed. The difference is 4.7 Å (between windows 30 and 10) in SDPC, which is less 
than the difference of 5.6 Å in SOPC (between windows 31 and 11).  
4.3.4 Behavior at aqueous interface 
In the replica exchange method, it is possible that neighboring windows swap their replicas 
and cause them to take a random walk between the windows [28]. In our simulations, we 
found examples of replicas that migrate through the interface between a window with αtoc 
entirely in water and a window with αtoc in contact with the membrane. The snapshots in 
Figure 4.4 give an illustration of the two states. With the trajectories of such replicas, we 
can take a close look at how αtoc leaves the membrane into the water and, vice versa, enters 
the membrane from water. When αtoc leaves the membrane, it begins from a state that has 
the chromanol head in the water and the phytyl tail is still inside the membrane and 
extended down into the interior (Fig. 4.4A). When αtoc becomes fully pulled into the water 
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(by replica exchange), the orientation of chromanol and the whole molecule including the 
phytyl tail quickly becomes random and surrounded by water (Fig. 4.4B). On the other 
hand, when αtoc enters the membrane from water, the phytyl chain encounters the 
membrane first. We did not find that water molecules penetrate into the membrane with 
the phytyl chain in this process. 
4.3.5 Flip-flop 
Between the equilibrium position (zeq) and the center of membrane (z=0), there is an 
increase in the PMF which denotes a barrier to the transverse movement of αtoc (Fig. 4.2). 
The barrier reflects that insertion of the hydrophilic OH group on the chromanol head group 
into the hydrophobic interior of the bilayer is energetically unfavorable. That the barrier in 
SDPC (ΔGflip = 1.9 kcal/mol) is lower than in SOPC (ΔGflip = 2.5 kcal/mol) indicates that 
flip-flop of αtoc from one side of the bilayer to the other is easier in the polyunsaturated 
than monounsaturated case (Table 4.1). This assessment is qualitatively consistent with the 
greater number of flip-flop events observed in SDPC compared to SOPC during our earlier 
conventional all-atom MD simulations [20]. A calculation of the rate of flip-flop now 
follows. 
To estimate the rate of flip-flop for αtoc, we adopt an approach applied to cholesterol in 
the past [27]. A complete flip-flop is defined as αtoc moving from zeq (equilibrium position) 
in one leaflet to zeq in the other leaflet. In this process the molecule moves from zeq to the 
membrane center (z = 0) and then to zeq on the other side of the bilayer. The respective rate 
constants 𝑘z and 𝑘7 that characterize these motions are related via   
                                                         𝑘z = 𝑘7𝑒9	∆qZ ,                                         (4.2) 
and equate to the rate of flip-flop 
                                                       𝑘z5EQ = %e}e × %&.                              (4.3) 
The factor of ½ is included in eq. 3 to take into account the possibility that an ɑtoc molecule 
that has reached the center of the membrane can return to its original leaflet as well as cross 
over to the other leaflet. An estimate of kd, was obtained by performing 10 standard MD 
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simulations with αtoc initially located at the center of membrane, and measuring the time 
(td) it takes to move back to zeq without harmonic restraint. 
Table 4.2 lists the results of our calculations. They reveal that the average rate of flip-flop 
rate 𝑘z5EQ is approximately 3 times greater in SDPC than in SOPC.  
4.3.6 Chromanol orientation 
To investigate how the orientation of the chromanol group on αtoc changes with depth in 
the membrane, we made two-dimensional probability histograms of 𝜌 𝑧, 𝜃  defined 
according to  
                                                         𝜌 𝑧, 𝜃 = / ,@y  hi @.                                         (4.4) 
In this equation 𝑧 is the distance from the center of the bilayer and 𝜃 is the angle that the 
C3-C6 vector on the chromanol group makes with the bilayer normal (Fig. 4.5A). To 
calculate the histogram, z and 𝜃 are divided into bins that are 0.5 Å and 1° in respective 
size. 𝑛(𝑧, 𝜃) is the incidence of being found in bin 𝑧 and 𝜃, 𝑁 𝑧  is the total incidence of 
being found in bin z, which is used to normalize the total probability density at different 𝑧, 
and sin 𝜃 in the denominator accounts for the change of bin size with respect to 𝜃. 
The two-dimensional histograms of orientation for the chromanol group obtained in SDPC 
and SOPC are plotted in Figure 4.5B. They are similar in the two membranes. As would 
be expected, the chromanol group has no preferred direction when the whole of the αtoc 
molecule is in water (z >35 Å). When the phytyl chain penetrates the bilayer (z <35 Å), it 
packs parallel to the surrounding phospholipid chains and the orientation of the chromanol 
group becomes constrained in a distribution that tends to line up with the bilayer normal 
(𝜃 = 0°). Near the disordered center of the bilayer (z ~ 0 Å), however, the situation changes 
and the distribution is almost uniform. It indicates that αtoc undergoes significant 
reorientation there, and that our simulations have a good sampling of the orientation of the 
chromanol. 
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4.4 Discussion 
The role of αtoc in the plasma membrane is to protect polyunsaturated phospholipids from 
oxidation, an activity that requires close contact with the lipid peroxyl radicals formed 
during the chain reaction by which oxidation proceeds. However, the global concentration 
of αtoc is small (< 1 mol% of all lipids) [15]. How αtoc can effectively protect the 
comparatively larger amount of polyunsaturated phospholipid remains a question. The 
answer might rely on the unique membrane properties of PUFA chains that contain 
multiple -C-C=C-C- units. The C-C bonds next to each C=C bond have a shallow rotational 
energy barrier, so that PUFA chains are tremendously disordered [29]. This disorder 
provides membrane environment necessary for the function of specific proteins [30]. It also 
produces an aversion for cholesterol that drives the formation of PUFA-rich domains [31], 
leading to the hypothesis that αtoc preferentially co-localizes with PUFA in such domains 
to increase the local concentration of αtoc around the lipid species most in need of 
protection from oxidation [14]. This hypothesized mechanism is analogous to the co-
localization of cholesterol with saturated sphingolipids in lipid rafts [32]. 
Our simulations reveal that there is higher binding energy for αtoc associated with SOPC 
(18.3 kcal/mol) than SDPC (16.7 kcal/mol) (Table 4.1). These values are comparable to 
the only other report to date of a binding energy from UBSMD simulation for αtoc (12.4 
kcal/mol in 1,2-dipalmitoylphosphatidylcholine(DPPC)) [33], although direct comparison 
is inappropriate given that the force field is not the same. The differential in value ∆∆𝐺 
between the two lipids that we measure can be related to a relative partition coefficient 𝐾v#"v"  = 13.3 (SOPC with respect to SDPC) via 
                                                              𝐾v#"v" = 𝑒9∆∆                                          (4.5) 
where 𝑅 and 𝑇 are the gas constant and temperature, respectively [34]. The trend is the 
same as seen for the binding of cholesterol between saturated and unsaturated lipids by 
both experiment and in UBSMD simulation [34,35]. Upon reflection, this observation is 
not too surprising given the similarity in molecular structure of cholesterol and αtoc. Like 
in the case of cholesterol, the more disordered lipid environment in the SDPC bilayer is 
responsible for the differences in binding energy for αtoc. The SDPC membrane is thinner 
and looser in the lipid packing (larger area per lipid) than the SOPC membrane. Thus, in 
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the PMF the change of G(z) is more gradual both near the center of membrane (from zeq to 
z0) and at the aqueous interface (z between 30-35 Å) in SDPC membrane compared to 
SOPC membrane (Fig. 4.2).  
The argument used in the cholesterol umbrella sampling study is that the difference in 
desorption energy (binding energy) for cholesterol in different lipid membranes is equal to 
the free energy change for cholesterol to exchange between different domains [35]. With 
the same argument, it appears that αtoc would have greater affinity for a more saturated 
lipid environment than a polyunsaturated DHA environment in the plasma membrane. This 
assessment contradicts the hypothesis that PUFA and αtoc co-localize together. However, 
there are still possible mechanisms that could support the hypothesis. The high 
concentration of cholesterol in lipid rafts, driven by its high affinity for saturated lipids, 
may exclude αtoc into regions that are PUFA-rich/cholesterol-poor. We suggest two 
possible future ways to investigate this problem. First, we can perform UBSMD 
simulations to compare the binding energy of αtoc to membranes with different cholesterol 
concentrations and unsaturation. We would then learn whether the presence of cholesterol 
reduces the affinity of αtoc to a more saturated environment. Second, we could try to 
investigate the partition of αtoc in different lipid domains directly, using larger scale 
simulation like coarse graining that can reproduce lipid domain formation in a bilayer [36]. 
In the windows where αtoc is sticking out from the membrane, we noticed deformation of 
the membrane (Fig. 4.3). It indicates that not only αtoc-PC interactions, but also PC-PC 
interactions, contribute to the binding energy ΔG. This issue has previously been ignored. 
In an USMD simulation study on cholesterol, for instance, the enthalpic contribution to the 
change in free energy is only represented by the interaction energy between cholesterol and 
water/PC [37]. We suggest that PC-PC interactions should be included as well. Replica 
exchange reveals the strongly hydrophobic nature of the behavior of αtoc near the aqueous 
interface (Fig. 4.4). The water layer that surrounds atoc molecule when it is in water does 
not follow it in to the bilayer hydrophobic interior. This avoids the possibility that a water 
pore forms during the simulation, which might affect the accuracy of the PMF by 
perturbing membrane order [38]. 
The smaller energy barrier at the center of the bilayer identified in the profile of PMF in 
SDPC and SOPC (Fig. 4.2) and the corresponding rate of flip-flop calculated (Table 4.2) 
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show that it is easier for αtoc to translocate across a highly disordered membrane interior. 
This difference qualitatively agrees with the greater number of flip-flop events observed 
for αtoc in SDPC than SOPC during the 200 ns over which our previous standard 
simulations were run [20]. The same trend of faster flip-flop in more unsaturated, 
disordered membranes was seen for cholesterol in MD simulations [35,37,39]. Fast flip-
flop for αtoc in SDPC implies the vitamin could easily penetrate the interior of a 
polyunsaturated bilayer to intercept lipid peroxyl radicals, which  would help in the 
protection against oxidation [20]. Our simulations also provide insight on the path that the 
flip-flop of αtoc takes. The orientation of the chromanol group remains upright and lined 
up with the bilayer normal until the center of the bilayer is reached in both SDPC and 
SOPC (Fig. 4.5B). In the vicinity bilayer, the orientation becomes random so that the 
chromanol group can invert and place the OH group towards the aqueous interface on the 
opposite side of the membrane. This scenario is similar to that envisaged for the flip-flop 
of cholesterol in lipid membranes studied by the USMD method [37,39]. 
In summary, our findings do not support the proposal that vitamin E binds preferentially to 
polyunsaturated phospholipids. The dynamics and organization of vitamin E in many 
respects resemble that of structurally similar cholesterol. 
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Table 4.1 
Energetic terms derived from the PMF profile of αtoc. 
 Binding Energy (kcal/mol) 
Flip-flop barrier 
(kcal/mol) 
Equilibrium depth 
(Å) 
SDPC 16.7±0.2 1.9±0.2 10.1 
SOPC 18.3±0.2 2.5±0.2 11.4 
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Table 4.2 
Kinetic properties of αtoc flip-flop in SDPC and SOPC at 310K. Data are taken from the 
average of 20 cases (2 αtoc in 10 standard MD simulations) - 16/20 cases in SDPC and 
15/20 cases in SOPC (αtoc did not reach equilibrium within 60 ns in the rest of the cases). 
The range of td and derived rate constants are shown for reference, as well as the average 
rate of flip-flop. 
  td (ns) 
 
kd (s-1) 
 
kf (s-1) 
 
kflip (s-1) 𝑘z5EQ (s-1) 
SDPC 8 to 55 1.3×10
8 to 1.8×
107 
5.7×106 to 8.3×
105 
2.7×106 to 4.0×
105 
7.5×105 
SOPC 8 to 60 1.3×10
8 to 1.7×
107 
2.2×106 to 2.9×
105 
1.1×106 to 1.4×
105 
2.5×105 
 
 
 
 
 
 
 
 
 
 
93 
 
 
 
Molecular structure of αtoc, SDPC and SOPC. 
 
 
Figure 4.1 
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Figure 4.2 
PMF for αtoc partitioning from water to the center of the bilayer in SDPC (red) and SOPC 
(green). The PMF was set to zero in the aqueous phase. Error bars are the standard error 
calculated using block averaging. The length of the time block is 10 ns. 
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Figure 4.3 
A) Average z coordinate of the phosphate atom on PC lipids as a function of lateral distance 
r from the αtoc at in different windows (different depths of the chromanol group). 
B) Snapshot of the system when αtoc has been half-pulled out from the membrane (SDPC). 
αToc is shown as a space-filling model, the head groups of PC lipid are shown in an orange 
surface representation and the acyl chains of PC lipids are shown as blue lines. 
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Figure 4.4 
Snapshots from the trajectory of one replica that swaps between the windows of αtoc in 
and out of the membrane - αtoc with the chromanol group restrained in the water and the 
phytyl chain inside the membrane (A), and with the whole molecule completely in water 
(B). αToc is shown as a space-filling model (chromanol group colored in light blue and 
phytyl chain colored in orange), water molecules within a distance of 5 Å from αtoc are 
shown as blue balls, and PC lipids with their head group within a lateral distance of 10 Å 
from αtoc are shown in licorice representation. 
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Figure 4.5 
Probability distribution for the orientation of the chromanol group on αtoc (A) as a function 
of depth in SDPC and SOPC (B). 
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CHAPTER 5. ARE ALL N-3 PUFA THE SAME? A 
COMPARISON OF EPA, DHA AND DPA BY MD SIMULATIONS 
5.1 Introduction 
Long chain omega-3 polyunsaturated fatty acids (n-3 PUFA) are a distinct class of fatty 
acids that have multiple double bonds, with the last double bond being located 3 carbons 
from the terminal methyl (n or ω) end of the chain [1]. They began to attract attention in 
the 1970’s when a low incidence of cardiovascular disease was noted in the Inuit 
population who consumed a diet rich in oily fish that contain an abundance of n-3 PUFA 
[2]. Since then many more health benefits have been discovered including in the treatment 
of neurological problems [3], relief of the symptoms of inflammatory disorders [4] and 
prevention of the progress of certain cancers [5]. The major source of n-3 PUFA in the diet 
is fish and extracted oil supplements [1]. Eicosapentaenoic acid (EPA, 20:5) with 20 
carbons and 5 double bonds at the 5, 8, 11, 14 and 17 positions and docosahexaenoic acid 
(DHA, 22:6) with 22 carbons and 6 double bonds at the 4, 7, 10, 13, 16 and 19 positions 
are the primary ones. Present in smaller concentration, and to which EPA often converts, 
is docosapentaenoic acid (DPA, 22:5) with 22 carbons and 5 double bonds at the 7, 10, 13, 
16 and 19 positions. DPA has only recently begun to be the subject of research, in contrast 
to EPA ad DHA that have been widely studied [6]. Although all three n-PUFA are similar 
in chemical structure, whether they have similar, unique or complementary impact upon 
health remains a matter of debate [7].  
A complete explanation of the mode of action for n-3 PUFA currently does not exist. 
Modulation of the organization of plasma membranes following the uptake of n-3 PUFA 
into phospholipids is among the potential mechanisms that have been identified [8-10]. The 
basic idea is a variation on the lipid raft concept [11]. According to this concept, 
predominantly saturated sphingolipids and cholesterol segregate into tightly packed 
nanodomains that coalesce into functional microdomains (rafts) within a surrounding sea 
of phospholipids that are less ordered. By incorporating into membrane phospholipids, 
highly disordered n-3 PUFA that have an aversion for cholesterol are then proposed to 
manipulate the composition and structure of the domains. One example of a scenario 
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envisaged, for instance, has the introduction of n-3 PUFA-containing phospholipids into a 
raft displacing cholesterol and breaking apart the domain [10]. Detergent extraction assays 
and imaging studies performed on cells treated with n-3 PUFA support the general premise 
[12,13]. Changes in the levels of other fatty acids due to cellular metabolism, however, 
complicate interpretation. A series of studies on model membranes of controlled 
composition carried out in our laboratories have started to provide insight [14-17]. They 
established that the partitioning of an n-3 PUFA-containing phospholipid between more 
ordered raft-like and less ordered non-raft environments is sensitive to molecular structure. 
A much greater tendency for DHA- than EPA-containing phosphatidylcholine (PC) to 
infiltrate raft-like domains was revealed, which we attribute to a differential in the disorder 
associated with DHA relative to EPA and speculate may indicate a variance in bioactivity. 
To better understand this behavior and the possible role that the structure of an individual 
n-3 PUFA plays in determining biological activity, we have run atomistic MD simulations 
to make a direct comparison of EPA, DHA and DPA and their interaction with cholesterol. 
All atom MD simulation opens up a perspective on molecular structure and dynamics 
within lipid membranes that is unprecedented in detail [18]. The reliability of this 
computational method has been ascertained in tests on well-characterized systems that 
successfully reproduce experimental measurements. It is an approach that has been 
tremendously influential in developing a comprehension of the physical properties of 
PUFA-containing phospholipids. Simulations published for DHA-containing PC bilayers 
more than a decade ago were instrumental in showing that the polyunsaturated chain is 
highly flexible, rapidly undergoing isomerization between conformations that include 
extended and bent configurations [19-21]. A reduced energy barrier for rotation about the 
single bonds in the recurring =C-C-C= unit possessed by PUFA is responsible, debunking 
an alternative view that the rigidity of multiple bonds would produce low flexibility. 
Subsequent analysis of simulations on a 1-stearoyl-2-
docosahexaenoylphosphatidylcholine (DHA-PC) bilayer in the presence of cholesterol 
showed that the steroid moiety prefers close proximity to the saturated stearic acid (SA) 
chain over the polyunsaturated DHA chain [22]. This finding corroborates an arrangement 
inferred from experimental measurements of the orientation of cholesterol and its solubility 
in polyunsaturated membranes [23]. Phenomenal disorder that pushes cholesterol away is 
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what distinguishes PUFA and renders membrane architecture particularly responsive to 
their presence. 
An investigation of how molecular organization in lipid bilayers is affected by differences 
in the structure of EPA, DHA and DPA is presented here. To this end, we performed 
atomistic MD simulations comparing 1-stearoyl-2-eicosapentaenoylphosphatidylcholine 
(EPA-PC), DHA-PC, 1-stearoyl-2-docosapentaenoylphosphatidylcholine (DPA-PC) and 
1-stearoyl-2-oleoylphosphatidylcholine (OA-PC) bilayers. Their molecular structure, 
together with cholesterol, is shown Figure 5.1. With a saturated chain at the sn-1 position 
and a polyunsaturated chain at the sn-2 position, DHA-PC, EPA-PC and DPA-PC are 
representative of a phospholipid into which n-3 PUFA have been taken up in the plasma 
membrane [24]. OA-PC serves as a monounsaturated control. The simulations were run on 
single component membranes and in the presence of 20 mol% cholesterol to characterize 
interaction with the sterol for each n-3 PUFA. Supplementary solid state 2H NMR 
experiments employing analogs of the phospholipids perdeuterated in the sn-1 chain were 
conducted for validation. 
5.2 Materials and methods 
5.2.1 MD simulations 
Atomistic MD simulations were performed on DHA-PC, EPA-PC, DPA-PC and OA-PC 
bilayers in the absence and presence of 20 mol% cholesterol. They run in the constant 
particle, pressure and temperature (NPT) ensemble. There were 98 PC molecules in the 
single component membrane simulations, and 80 PC molecules and 20 cholesterol 
molecules in the two-component membrane simulations. In each case, the membrane was 
hydrated with 2000 water molecules. The initial structure of OA-PC, OA-PC + cholesterol, 
DHA-PC and DHA-PC + cholesterol bilayers was assembled with the CHARMM-GUI 
Membrane Builder [25]. Then, by modifying the DHA chain on DHA-PC molecules, the 
initial structure of EPA-PC + cholesterol and DPA-PC + cholesterol bilayers was generated 
from our assembled DHA-PC + cholesterol bilayer. The initial structure of EPA-PC and 
DPA-PC bilayers was created by locating the corresponding lipid molecule into a bilayer 
grid with a customized script. This approach avoided atom/chain conflicts that appear in 
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the initial structure when it is directly modified from the assembled DHA-PC bilayer. All 
simulations were run using the CHARMM C36p force field [26]. Non-bonded (van der 
Waals and short-range electrostatic) interactions were gradually switched off at 10 Å, and 
the long-range electro static interactions were calculated using the particle-mesh Ewald 
method [27]. The membranes were equilibrated with the standard CHARMM-GUI six-step 
process over 200 ps [25] during which constraints on lipids were gradually released 
CHARMM [28]. 
Production runs of our simulations were performed with NAMD [29] on the Big Red II 
super computer at Indiana University. Each one was run over 200 ns using a time step of 2 
fs, with the first 20 ns considered to be equilibration. In all simulations, periodic boundary 
conditions were applied to a rectangular box on which the x and y dimensions (in the plane 
of the membrane) were kept equal while the z dimension (in the direction of the membrane 
normal) was varied independently. The temperature was kept at 37 °C by the Hoover 
thermostat [30] and the Langevin piston method was applied to keep the pressure at 1 atm 
[31]. Analyses of simulations, including calculating order parameters and densities of 
atoms in 1- and 3-dimensions were achieved with customized Tcl script executed in the 
VISUAL MOLECULAR DYNAMICS (VMD) program [32]. Snapshots of bilayers and 
illustrations were also created with VMD, and rendered by blender. 
5.2.2 Solid state 2H NMR 
Details of solid state 2H NMR experiments are provided in Supporting Information. 
5.3 Results and discussion 
5.3.1 Molecular organization in single component membranes  
From our simulations on EPA-PC, DHA-PC and DPA-PC bilayers, differences in how each 
n-3 PUFA affects acyl chain order within membranes and the thickness of a bilayer were 
identified. 
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5.3.1.1 Membrane order 
The order parameter 𝑆"# is a fundamental quantity describing the dynamics of acyl chain 
segments in a membrane that is accessible by MD simulations and solid state 2H NMR 
spectroscopy [33]. It is a measure of the anisotropy of motion for the C-H (H is replaced 
by 2H in 2H NMR experiments) bond on a methylene or methyl group in an acyl chain. The 
definition of the order parameter is 
       𝑆"# = ¡ 3 𝑐𝑜𝑠& 𝛽 − 1          (5.1) 
where 𝛽  is the angle between the C-H bond on a particular chain segment and the 
membrane normal about which the reorientation of the chain is axially symmetric [34]. The 
angular brackets signify a time average that is also taken over all the molecules in a 
simulation. In the case of methylene groups and the terminal methyl group, an average 
order parameter for the two and three C-H bonds in the respective segments is usually 
calculated. An exception is the two C-H bonds on the methylene group at the C2 position 
of the sn-2 chain for which constraints on orientation due to the glycerol backbone lead to 
order parameters that are unequal [35]. A range 0 ≤ 𝑆"# ≤ 0.5 typically applies to the 
value for 𝑆"# [17]. The upper limit corresponds to a methylene group undergoing fast axial 
rotation in an all-trans chain (𝛽= 90°) while the lower limit corresponds to isotropic motion 
(𝛽 takes all angles) for a methylene or methyl group. 
Figure 5.2 (upper panel) shows the order parameter profiles obtained from simulation along 
the saturated SA chain at the sn-1 position in EPA-PC, DHA-PC, DPA-PC and OA-PC. 
They all display a form that is a signature for saturated phospholipid acyl chains in the 
lamellar liquid crystalline phase [34]. In the top half of the chain the 𝑆"# values exhibit a 
plateau region of approximately constant order (𝑆"#  ~ 0.2, C4-C8 positions), and then 
progressively decrease in the bottom half toward the terminal methyl group (𝑆"# ~ 0.02, 
C18 position) near the center of bilayer. Reorientation is constrained by tighter packing in 
the upper portion where the chain is anchored at the hydrophilic interface, while in the 
lower portion there is increasingly less restriction to motion towards the free end at the foot 
of the chain. Inspection of the profiles reveals the reduction in order expected to accompany 
the presence of a polyunsaturated sn-2 chain, which we quantify in terms of an average 
order parameter 𝑆"# that represents the global effect on the entire sn-1 chain (Table 1). 
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Among the PUFA-containing phospholipids, EPA-PC (𝑆"# = 0.131 ± 0.003) is the most 
disordered while DPA-PC (𝑆"# = 0.139 ± 0.003) is the least disordered. DHA-PC (𝑆"# = 
0.136 ± 0.003) lies in between, somewhat closer to DPA-PC. They are all ~10% less 
ordered than monounsaturated OA-PC (𝑆"# = 0.152 ± 0.003). 
The trends seen here are consistent with those observed experimentally by 2H NMR with 
analogs of PC deuterated in the sn-1 chain. Order parameter profiles published for the SA 
sn-1 chain in a series of PC membranes as a function of the level of unsaturation in the sn-
2 chain demonstrated that increasing the number of double bonds from 1 to 3 substantially 
decreases order [36]. Thereafter the changes in order on increasing the number of double 
bonds from 3 to 6 are modest, like we saw in our simulations on n-3 PUFA-containing 
bilayers with 5 (EPA-PC and DPA-PC) and 6 (DHA-PC) double bonds. The hierarchy of 
disorder EPA-PC (most disordered) > DHA-PC > DPA-PC (least disordered) identified by 
simulation qualitatively reproduces the variation of the average order parameter previously 
measured by us using moment analysis [37] and of the smoothed order parameter profiles 
constructed from FFT depaked spectra in the current work (Fig. A3.1 and Table A3.1 in 
Supporting Information). To the best of our knowledge an order parameter profile has not 
been reported for DPA-PC before. DPA*-PC with DPA* (n-6 isomer) containing 20 
carbons and 5 double bonds at 4, 7, 10, 13 and 16 positions, as opposed to DPA (n-3 
isomer), for the sn-2 chain was compared with DHA-PC in earlier work [38]. As with DPA-
PC, the SA sn-1 chain in DPA*-PC was found to be slightly less disordered than DHA-PC 
(∆𝑆"# = 0.008). 
The order parameters that were calculated for the unsaturated sn-2 chain in EPA-PC, DHA-
PC, DPA-PC and OA-PC are plotted as function of position in Figure 5.2 (lower panel). 
Not surprisingly, there is a big difference between the OA chain and PUFA chains. The 
OA chain in OA-PC has a profile that is similar to the SA sn-1 chain, apart from positions 
C8-C11 where there is big drop in the magnitude of 𝑆"# . This phenomenon was first 
observed experimentally and is understood [39,40]. A localized region of enhanced 
segmental motion within the OA chain is not the reason for the reduced order parameters. 
The configuration of the chain around the rigid cis double bond, instead, produces a most 
probable orientation for which the order parameters of the C-H bonds on the chain 
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segments at (C9 and C10) and flanking (C8 and C11) the double bond are inherently low 
– i.e. 𝛽 takes angles near the “magic” angle (54.7°) at which the second order Legendre 
polynomial in the definition of the order parameter (eq. 1) goes to zero. 
Compared to the OA chain in OA-PC, the order parameters for the PUFA chain in EPA-
PC, DHA-PC and DPA-PC are much lower. They are less than 0.05 throughout the bottom 
two-thirds of the chain (C7 to the end), which is comparable to the value of 𝑆"# for the 
highly mobile methyl group at the free end of a chain. An almost uniform distribution from 
0 to 180° for the value of the angle 𝛽 that the C-H bonds make with the bilayer normal is 
responsible. The truly high disorder implied is the result of the shallow energy barrier to 
rotation about C-C bonds in the repeating =CH-CH2-CH= motif that distinguish PUFA 
with their multiple double bonds from less unsaturated fatty acids [41]. This behavior is 
well documented by simulation and experiment in the case of DHA [26,42-44]. Higher 
order exists in the uppermost portion of the PUFA chains before the sequence of double 
bonds begins. The effect is most pronounced in DPA where the first double bond does not 
occur until carbon C7 (Fig. 5.1). The order parameter (𝑆"# ~ 0.17) at positions C3-5 of the 
DPA chain in DPA-PC approaches the value seen at the same positions for OA in OA-PC 
(𝑆"# ~ 0.20) (Fig. 5.3). A similar plateau-like region of elevated order is found in the profile 
for neither DHA in DHA-PC nor EPA in EPA-PC. We attribute its presence in DPA to the 
removal of the double bond at the C4 position relative to DHA and to the addition of two 
methylene groups prior to the first double bond relative to EPA (Fig. 5.1). In response, 
order parameters in the SA sn-1 chain are higher for DPA-PC than DHA-PC and, to greater 
extent, EPA-PC. The lower order of the SA chain in EPA-PC than DHA-PC indicates that, 
as we have previously surmised [37], the ordering associated with the loss of a double bond 
is more than compensated by the disordering associated with the shortening of the chain 
on replacing DHA by EPA. 
5.3.1.2 Membrane thickness 
Electron density profiles (EDP) across the membrane that were calculated for EPA-PC, 
DHA-PC, DPA-PC and OA-PC are shown in Figure 5.3 (upper panel). They were 
generated from histograms of the atoms in lipids along the bilayer normal (z direction) that 
were weighted by the number of electrons associated with each atom. Because the area of 
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membrane that was simulated is too small to undulate, the z direction in our system well 
represents the membrane normal [45]. In the EDP of each membrane, there is a dip in the 
middle (z = 0) of the bilayer reflecting where the highly disordered methyl groups at the 
end of acyl chains reside. The peaks on both sides correspond to the electron dense head 
group at the edge of the membrane and, as illustrated (Fig. 5.3, upper panel), approximate 
to the location of the phosphate group. Their separation is commonly taken to be the 
membrane thickness [46] and was used by us to determine the 𝐷¦¦ values listed in Table 
2. The agreement with experimental data that exist in the literature for OA-PC (38.7 Å) 
[47] and DHA-PC (37.9 Å) [38] is good (within 1 Å). As far we know 𝐷¦¦ has not been 
measured for EPA-PC and DPA-PC, although in the latter case a thickness has been 
reported from X-ray work for its n-6 isomeric counterpart DPA*-PC (37.9 Å) [38]. 
It is generally recognized that introducing double bonds into a lipid chain causes a thinning 
of the bilayer [48]. A lipid chain with a double bond, and more markedly with multiple 
double bonds, is more disordered and occupies a larger cross-sectional than a saturated 
chain with same number of carbons. The result is a thinner bilayer. The measurements of 
membrane thickness obtained from our simulations conform to the gist of this view (Table 
2). They demonstrate that DPA-PC, DHA-PC (22 carbons) and EPA-PC (20 carbons) with 
a polyunsaturated sn-2 chain are comparable in thickness or thinner than OA-PC (18 
carbons) with a shorter monounsaturated sn-2 chain. As an aside, we point out that the 
values of 𝐷¦¦ measured from the EDP generated from our simulations underscore that care 
should be exercised when relating the average order parameter for the saturated sn-1 chain 
(Table 1) to membrane thickness. The basic idea connecting the two parameters is that a 
more ordered sn-1 chain has a bigger projected length, corresponding to greater bilayer 
thickness [49]. However, despite an average order parameter for the SA sn-1 chain in DPA-
PC that is almost 10% lower than in OA-PC, the thickness of the n-3 PUFA containing 
bilayer is slightly bigger. The length of the sn-2 chain is clearly a factor. 
5.3.2 Molecular organization in membranes containing cholesterol 
From simulations run in the presence of 20 mol% cholesterol, we compared how acyl chain 
order within the membrane and the thickness of the bilayer were affected in EPA-PC, 
DHA-PC and DPA-PC. To further assess interaction with the sterol, the location and 
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orientation of cholesterol within the bilayers were determined and the distribution of each 
chain around the steroid moiety was mapped. 
5.3.2.1 Membrane order 
The addition of 20 mol% cholesterol to EPA-PC, DHA-PC and DPA-PC produces the 
anticipated increase in order within the bilayer [50]. Order parameters are elevated along 
the entire SA chain at sn-1 position in each case, reflecting the constraint upon reorientation 
imposed by the rigid sterol molecule (Fig. 5.4, upper panel). The shape of the profile 
remains largely unchanged. There is still a relatively flat region of approximately constant 
order parameter in the upper portion of the chain before order drops off in the lower portion 
towards the terminal methyl group. As judged by estimates of the average order parameter 
(Table 1), all three n-3 PUFA containing bilayers undergo essentially the same rise in order 
(∆𝑆"# ≈ 0.040) due to cholesterol so that the hierarchy of order between them is retained - 
DPA-PC (𝑆"# = 0.182 ± 0.003) > DHA-PC (𝑆"# = 0.178 ± 0.003) > EPA-PC (𝑆"# = 0.169 
± 0.003). The sterol-induced ordering is less than seen for the SA chain in OA-PC (∆𝑆"# 
= 0.061), which results in the greater differential in order between the n-3 PUFA- and OA-
containing bilayers that is apparent on inspection of the profiles obtained with (Fig. 5.4, 
upper panel) and without (Fig. 5.2, upper panel) cholesterol. It has similarly been surmised 
from experimental results presented in earlier studies there is a smaller increase in order 
due to cholesterol for polyunsaturated vs. monounsaturated bilayers [51,52]. 
A substantially more modest increase in order occurs for the n-3 PUFA chain at the sn-2 
position in EPA-PC, DHA-PC and DPA-PC following the introduction of cholesterol than 
for the SA chain at the sn-1 position (Fig. 5.4, lower panel). The shift in average value for 
the order parameter (∆𝑆"# < 0.015) is correspondingly smaller and comparable in each case 
(Table 1). There is little change in the overall shape of the profile. Despite the presence of 
the rigid steroid moiety, the n-3 PUFA chains are still highly disordered with order 
parameters that are low throughout much of their length (𝑆"# < 0.08 in the bottom two 
thirds). In contrast, the order of the OA sn-2 chain in OA-PC is elevated to a much greater 
extent by cholesterol. It increases by an amount ( ∆𝑆"#  = 0.055) approaching that 
undergone by the saturated SA sn-1 chain, retaining the form of the profile observed in the 
absence of the sterol. The effect of cholesterol on the order parameter profile for the DHA 
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sn-2 chain in DHA-PC derived from our simulations parallels the results obtained from 
NMR spectra [52]. Experimental measurements of the order parameter in the OA sn-2 
chain of OA-PC are too sparse to make a meaningful comparison, while we are unaware 
that order parameters in either the EPA sn-2 chain of EPA-PC or DPA sn-2 chain of DPA-
PC have been experimentally determined. 
5.3.2.2 Membrane thickness 
A thickening of EPA-PC, DHA-PC and DPA-PC, as well as of OA-PC, that follows the 
introduction of cholesterol is evident in the EDP constructed in Figure 5.3 (lower panel). 
It is a manifestation of the condensing effect of the sterol - the projected length of 
phospholipid chains ordered by cholesterol is greater and the bilayer becomes thicker [53]. 
All three of the n-3 PUFA-containing membranes undergo a comparable increase in 
thickness (∆𝐷¦¦ = 3.2-3.8 Å) that is less than the change undergone by the OA-containing 
membrane (∆𝐷¦¦  = 4.6 Å) (Table 2). As would be expected, the magnitude of these 
changes qualitatively parallels the elevation in molecular ordering due to cholesterol (Table 
1). In agreement with these simulation-based findings, that the sterol produces a smaller 
increase in the width of DHA-PC compared to OA-PC bilayers may be gleaned from 
reports of neutron and x-ray scattering data [52,53]. 
5.3.2.3 Location of cholesterol 
Cholesterol usually resides in a membrane with the hydroxyl group at one end of the 
tetracyclic ring near the aqueous interface while the short chain at the opposite end extends 
towards the center of the membrane [50]. An exception is bilayers that are thin (𝐷¦¦ < 30 
Å) in which hydrophobic mismatch drives the sterol into the interior of membrane where 
it straddles both leaflets [48]. This latter situation does not apply to the systems in the 
current study. The partial EDP generated from the simulated data for [2,3,4]- and 
[25,26,27]-carbons on cholesterol in EPA-PC, DHA-PC, DPA-PC and OA-PC conform to 
the canonical arrangement (Fig. 5.5, upper panel). They place the head and tail of the sterol, 
respectively, just below the surface and in the middle of the bilayer. 
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5.3.2.4 Orientation of cholesterol 
The motion of cholesterol can be modeled as a fast rotation about the bilayer normal for 
the long molecular axis that in addition fluctuates in direction about a most probable 
orientation (tilt angle) offset from the normal [54]. Figure 5.5 (lower panel) shows the 
probability distribution calculated here for the angle a vector connecting the C13-C10 
carbons, designating the alignment of the steroid moiety, makes with the bilayer normal in 
EPA-PC, DHA-PC, DPA-PC and OA-PC. A shift to larger angle and a broadening of the 
entire distribution accompanies the increase in disorder on replacing OA by each n-3 
PUFA. It is clear, however, that there is little variation (< 2°) in the most probable 
orientation, denoted by the maximum in the distribution, between the various systems 
(Table 3). This observation is consistent with 2H NMR work on [3α-2H1]cholesterol, an 
analog of the sterol labeled at the 3α position, incorporated at 50 mol% into PC bilayers 
with SA at the sn-1 position [55]. These experiments revealed the tilt angle is almost 
independent of the level of unsaturation for the sn-2 chain 
5.3.2.5 Interaction of cholesterol with acyl chains 
As a molecule that orders the membrane, cholesterol does so by interacting with the nearby 
fatty acid chains. The local lipid environment around the sterol molecule, thus, reflects how 
it interacts with the surrounding lipids. To analyze the packing around cholesterol of the 
fatty acyl chains in our study, a two-dimensional radial distribution function (RDF) 
       𝑔 𝑟E = y GZ&§GZ¨ G©           (5.2) 
was generated [56]. In this equation 𝑟E is the distance from a selected atom on the steroid 
moiety (defined as the central atom) to the carbon atom on an acyl chain (sn-1 or -2) of the 
phospholipid, and 𝑁 𝑟E  is the number of acyl chain carbons inside a bin at distance 𝑟E and 
at the same depth (±1 Å in the z direction) within the bilayer as the central atom. The term 
          𝜌 𝑟ª = y G©&§G©           (5.3) 
represents the overall density of acyl chain atoms in the membrane, with r∞ set to 25 Å in 
practice. C10 and C13 were chosen as the central atom. Of the series of peaks in the RDF 
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obtained (Fig. 5.6), we focus on the first one that reflects the arrangement of the chains 
closest to a cholesterol molecule. 
Differences in the packing around cholesterol for the SA chain at the sn-1 position and for 
the OA and n-3 PUFA chains at the sn-2 position are immediately apparent in the RDF 
calculated with C10 for the central atom (Fig. 5.6, upper panel). The RDF for the SA sn-1 
chain has a similar shape in each case. The first maximum at distance of about 6 Å is a 
well-defined single peak. By contrast, the RDF for the unsaturated sn-2 chain differs in 
each case. In OA-PC the first maximum for the OA chain is reduced in height compared to 
the SA chain and, suggesting the presence of two peaks that do not precisely overlap, there 
is a hint of asymmetry. The reduction in height of the first maximum for the DPA chain in 
DPA-PC is more marked, as is its asymmetry. There is further reduction in height and a 
better-defined separation into two peaks for the DHA chain in DHA-PC and the EPA chain 
in EPA-PC. These observations indicate that the PUFA, and to less extent OA, chains do 
not pack around cholesterol as tightly as the SA chain. The greater order of the saturated 
SA chain means that it adopts a more linear conformation that is able to lie parallel to the 
planar faces of the tetracyclic ring of the sterol. The higher disorder of the OA and, much 
more markedly, DPA, DHA and EPA chains produces an irregular configuration that is 
less compatible with close proximity, resulting in a distribution that is more spread out and 
uneven.  
We also calculated RDF lower down the steroid moiety by choosing C13 to be the central 
atom (Fig. 5.6b). The first maximum for the sn-1 chain in all cases is less sharp than when 
C10 is the central atom. This change is due to the higher disorder that exists deeper in the 
bilayer where the C13 position is located. The same argument applies to the shape of the 
first maximum in the RDF for the sn-2 chains. The OA and DPA chains have a first 
maximum that is more clearly split into two peaks in the case of C13 position because the 
chains are more disordered. For DHA and EPA the difference between the C10 and C13 
cases is less, which we attribute to near uniform high disorder that these chains possess 
throughout their entire length. 
The sterol ring on cholesterol is not symmetric. It has a planar structure that is flat on one 
side (α face) and has two methyl groups poking out on the other bumpy side (β face) (Fig. 
5.7, upper panel). Given this molecular structure, the surrounding phospholipid chains are 
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not expected to pack equally with respect to the two faces. To map the azimuthal 
distribution, and so elaborate upon the RDF described above (Fig. 5.6), we generated a 
number density profile (NDP) for the carbon atoms on the acyl chains with respect to an 
axis system (x',y',z') fixed in the cholesterol molecule. All 20 cholesterol molecules in our 
simulation were registered to a common frame of reference in which the C13 atom was 
chosen to be the origin, the C13-C18 vector was fixed on the x' direction and C13-C10 
vector was kept in the x'z' plane (Fig. 5.7, upper panel). The space around sterol molecules 
was then divided into bins 0.5×0.5×0.5 Å3 in size, and the number density of specified 
atoms on phospholipid molecules in each bin was counted through 180 ns of trajectory 
using a sampling rate of 50 frames per ns. Because of the consistent registration of 
coordinates, the NDP for all 20 cholesterol molecules could be simply added up. We 
computed in this way the NDP for the carbon atoms on the sn-1 or -2 chain of phospholipids 
within 1 nm distance from the origin on cholesterol in each system. A slice taken at z' = 0 
(Fig. 5.7, lower panel) illustrates the set-up of the map of the spatial position of N(x',y') 
obtained. 
Two ring-like structures around the cholesterol molecule can be discerned in the NDP for 
the sn-1 (Fig. 5.8, left column) and -2 chains (Fig. 5.8, right column) on OA-PC, DPA-PC, 
DHA-PC and EPA-PC in the slice taken at z' = 0. The first (inner) ring, which is 10-12 Å 
in diameter, maps the distribution of the chains closest to the sterol and follows the shape 
of the flat α face on the left and the bumpy β face on the right. The second ring, which is 
approximately 20 Å in diameter, maps the distribution of the chains in the next layer out 
and is fuzzier. The pattern for the NDP is unique in each case. For OA-PC, the inner ring 
for the SA and OA chains is thinner and better defined compared to the corresponding 
chains in the polyunsaturated systems. In addition, the gap between the first and second 
rings is clearer for the saturated sn-1 chain than for the monounsaturated and, more 
markedly, polyunsaturated sn-2 chains. These general features quantitatively agree with 
our assessment from the two-dimensional RDF plots - the packing of SA at the sn-1 
position is tighter around cholesterol than OA and, even more so, DPA, DHA and EPA at 
the sn-2 position.   
The NDP plots also probe how the density of the nearest neighbor chains in the first ring 
varies with orientation around the sterol (Figur. 5.8). Regions of highest density, which 
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indicate where a chain is most likely to be found, are apparent at the 1, 4, 9 and 11 o’clock 
positions for the SA chain and at the 4 and 7-10 o’clock positions for the OA chain in OA-
PC. The region of high density for the latter chain at the 7-10 o’clock positions indicates 
that to some extent OA favors the flat surface of cholesterol. There is less heterogeneity in 
density for the more disordered chains in the n-3 PUFA containing membranes. In DPA-
PC, the SA and DPA chains have highest density at the 1, 4 and 9 positions and the 4 and 
11 positions, respectively. The regions of high density are less pronounced than in OA-PC 
and, in contrast to the OA chain, the DPA chain does not exhibit any preference for the flat 
face of the sterol. An almost homogenous distribution of density exists for the SA chain in 
DHA-PC, while regions of high density occur at the 1 and 9 o’clock positions for the DHA 
chain. As in DPA-PC, the regions of high density are not as distinct as in OA-PC. In EPA-
PC, the ost disordered of the three n-3 PUFA-containing membranes, the distribution of 
both SA and EPA chains ultimately becomes homogenous.   
The preference of the OA chain in OA-PC for the flat face of cholesterol exhibited in our 
NDP plots is contrary to the assessment made in simulations comparing RDF between the 
CH=CH on the phospholipid and CH3 group at the C13 position on cholesterol in 1-
palmitoyl-2-oleoylphosphatidycholine (POPC), which has saturated palmitic acid at the sn-
1 position and OA at the sn-2 position, and 1,2-dioleoylphosphatidylcholine (DOPC), 
which has OA at sn-1 and -2 position, bilayers [27]. In this earlier work greater disparity 
in height between the first and second peaks in POPC compared to DOPC was attributed 
to OA preferring the bumpy face. It is an interpretation, however, made without the 
definitive insight into orientation provided by our NDP plots. The higher density for DHA 
than SA seen in the inner ring closest to cholesterol of our NDP plots with DHA-PC is 
another observation that contradicts previously published simulations [22]. Probability 
density distributions around the sterol were calculated showing a shell-like structure, 
similar to the rings in the NDP plots reported here, in which solvation by SA over DHA is 
preferred. Possible reasons for the discrepancy between findings include the use in the 
current simulations of an updated version of the force field (CHARMM36p vs. 
CHARMM27) and of the more physically realistic NPT ensemble (as opposed to the 
constant-energy, constant-volume ensemble (NVE)). 
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5.3.3 Biological implications 
In conclusion, our MD simulations on DPA-PC, DHA-PC and EPA-PC confirmed that the 
n-3 PUFA increase disorder within a membrane and interact less favorably with cholesterol 
compared to monounsaturated OA in an OA-PC control. Differences between the 
molecular organization of the three n-3 PUFA and their interaction with cholesterol were 
revealed. EPA and DPA create most disorder and least disorder, respectively, while the 
effect of DHA lies between them. The differential in order between them is modest (~ 5%), 
as quantified by the average order parameter of the SA chain at the sn-1 position, yet affects 
their ability to pack close to cholesterol. It is, moreover, of potential significance in 
understanding the dietary impact of the n-3 PUFA found in fish oils. 
The lipid raft concept offers an example of potential sensitivity to the amount of disorder 
produced by a particular n-3 PUFA. According to this concept, nano-sized domains 
enriched in sphingolipid and cholesterol that are liquid ordered (lo) and contain signaling 
proteins float in a sea of surrounding bulk lipid that is liquid disordered (ld) in the plasma 
membrane [58]. When the rafts coalesce together, they become functionalized. A variation 
on this scenario has incorporation of n-3 PUFA into the phospholipids of the bulk lipid fine 
tuning the clustering of rafts via the increased differential in order between within raft and 
non-raft environments that results [17,59]. In support of this proposal, we recorded solid 
state 2H NMR spectra for deuterated analogs of EPA-, DHA and OA-containing PC in 
mixtures with SM and cholesterol (1:1:1 mol) that were analyzed in terms of segregation 
into SM-rich/cholesterol-rich (raft-like) and PC-rich/cholesterol-poor (non-raft) domains 
[16]. Two-component spectra indicating slow exchange between domains larger in size (r 
> 35 nm) were obtained with EPA, whereas single component spectra indicating fast 
exchange between domains smaller in size (r < 45 nm) were obtained with OA. Consistent 
with a smaller reduction in order, spectra indicative of intermediate exchange between 
domains that fall in size between the limits estimated for EPA and OA were obtained with 
DHA. Whether signaling proteins in rafts are turned on or off, thus, may depend upon the 
n-3 PUFA incorporated into membrane phospholipids.  
The smaller reduction in order produced by DPA compared to EPA is also a factor that 
should be borne in mind when assessing the efficacy of EPA. Specifically, fatty acid 
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analyses of the composition of cells fed EPA have shown that substantial elongation to 
DPA can occur [6]. In such cases, the increase in disorder anticipated in response to uptake 
of EPA would be reduced. The similar effect on membrane order, for instance, was seen in 
B lymphoma cells treated with EPA and DHA was ascribed in part to elongation of EPA 
to DPA. 
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Table 5.1 
Membrane thickness (DHH) measured by phosphate-phosphate distance (Å). The 
uncertainty is ±0.09 Å, estimated from the standard error of the peak locations. 
 OA-PC DPA-PC DHA-PC EPA-PC 
Pure 39.6 39.7 38.4 37.5 
With 
cholesterol 
44.2 42.9 42.2 40.7 
Change 4.6 3.2 3.8 3.2 
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Table 5.2 
Average order parameters of sn-1 chain and sn-2 chain from OA-PC, DPA-PC, DHA-PC 
and EPA-PC membranes without and with 20 mol% of cholesterol.  
 
Lipids 
𝑆"# 
Sn-1 Sn-2 
Without Cholesterol With cholesterol Without Cholesterol With cholesterol 
OA-PC 0.152 0.214 0.114 0.170 
DPA-PC 0.140 0.182 0.047 0.062 
DHA-PC 0.136 0.178 0.031 0.041 
EPA-PC 0.131 0.169 0.032 0.044 
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Figure 5.1 
Molecular structure of OA-PC, DPA-PC, DHA-PC, EPA-PC and cholesterol. 
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Figure 5.2 
Order parameter profile along the sn-1 (upper panel) and -2 (lower panel) chains in OA-
PC (red), DPA-PC (yellow), DHA-PC (blue) and EPA-PC (green) bilayers obtained from 
MD simulations at 37°C. The uncertainty in the simulated data is ≤±0.003 in sn-1 chain 
and ≤±0.002 in sn-2 chain, which was estimated from the standard error obtained treating 
each lipid molecule independently. The uncertainty is smaller in more disordered (lower 
SCD value) carbon positions. 
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Figure 5.3 
EDP for all atoms (above) and the number density profile of phosphorus atom (below) on 
the phospholipid in OA-PC, DPA-PC, DHA-PC and EPA-PC bilayers without cholesterol 
(upper panel) and with addition of 20 mol% cholesterol (lower panel). The phosphate 
curves are scaled and shifted for clarity. 
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Figure 5.4 
Order parameter profile along the sn-1 (upper panel) and -2 (lower panel) chains in OA-
PC (red), DPA-PC (yellow), DHA-PC (blue) and EPA-PC (green) bilayers following the 
addition of 20 mol% cholesterol obtained from MD simulations at 37°C. The uncertainty 
in the simulated data is ≤±0.003 in sn-1 chain and ≤±0.002 in sn-2 chain, which was 
estimated from the standard error obtained treating each lipid molecule independently.  The 
uncertainty is smaller in more disordered (lower SCD value) carbon positions. 
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Figure 5.5 
Carbon number density profile for the [2,3,4]-carbons (headgroup) and [25,26,27]-carbons 
(tail) on cholesterol (upper panel) and histogram of the orientation of cholesterol (vector 
connecting the C13-C10 carbons) relative to the bilayer normal (lower panel) in OA-PC, 
DPA-PC, DHA-PC and EPA-PC bilayers. 
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Figure 5.7 
Coordinate system (x',y',z') used in the number density profile (NDP) generation relative 
to the cholesterol molecule (upper panel) and an example of one slice illustrating the set-
up of the NDP relative to cholesterol in OA-PC (lower panel). The color scale is the same 
as in Fig. 5.8. 
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CHAPTER 6. CONCLUSIONS 
The main focus of my thesis was characterizing lipid-lipid interaction and lipid dynamics 
in the PUFA-incorporated lipid membranes. The major techniques applied were standard 
MD simulation and USMD simulation. In this chapter I will summarize the work done and 
suggest possible future directions.  
6.1 Vitamin E and PUFA 
In Chapter 3, we performed standard MD simulations on αtoc in SDPC bilayers, compared 
with in SOPC bilayers as a control [1]. SDPC represents a PUFA-incorporated 
phospholipid found in the plasma membrane, and SOPC is monounsaturated and a common 
bulk lipid in plasma membrane. The simulations were first qualitatively validated by 2H 
NMR order parameters obtained experimentally. As a molecule that has similar chemical 
structure to cholesterol, αtoc also orders the corresponding membranes [2,3]. Then 
comparison was made with neutron scattering data that established there was reasonable 
agreement on membrane thickness and the disposition of αtoc in the membranes. 
We analyzed the interactions between αtoc and different acyl chains in terms of the vdW 
energy, and further generated a probability distribution function mapping the location of 
carbon atoms on the lipid chains near αtoc. We found that the DHA chain on SDPC is more 
likely to come into close proximity with the chromanol ring on αtoc than the OA chain on 
SOPC. Moreover, flip-flop of αtoc across the bilayer was observed and its rate is about an 
order of magnitude faster in SDPC than in SOPC. The differences between SDPC and 
SOPC were attributed to the highly disordered nature of DHA chains. A DHA chain is so 
flexible that its lower portion can reach the aqueous interface more easily than OA [4], so 
that the chromanol group, which sits close to the aqueous interface, has a better chance of 
contact with DHA. The disordered DHA chain also reduces lipid packing, allowing the 
chromanol ring to penetrate the hydrophobic bilayer interior more easily. The shielding 
provided by the methyl groups on either side of the OH group on the chromanol group 
plays a crucial role in letting αtoc to enter the bilayer.  
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From these results, we conclude that the behavior of αtoc in a PUFA-containing membrane 
would assist its antioxidant function. The enhanced likelihood of DHA meeting the 
chromanol group would help the OH group meet and react with lipid peroxyl radicals to 
stop oxidation. Rapid flip-flop of α-toc across the polyunsaturated phospholipid bilayer 
would also facilitate termination of lipid chain peroxidation within a membrane as well as 
at the surface.  
To investigate whether αtoc preferentially interacts with PUFA-containing lipid, we 
performed umbrella sampling MD simulations to calculate its binding energy to lipid 
bilayers in a subsequent described in Chapter 4. Again we selected SDPC and SOPC to 
represent the polyunsaturated and monounsaturated lipids, respectively. The vertical 
(membrane normal) distance between the center of mass of αtoc’s chromanol group and 
the center of the bilayer was chosen to be the reaction coordinate z. The free energy (G(z)) 
as a function of z was then calculated from umbrella sampling simulations through WHAM. 
Defining the binding energy as the difference ∆𝐺6E/7 between zout (where αtoc is fully in 
water) and zeq (where αtoc is at its equilibrium position), the values obtained for ∆𝐺6E/7 
are 16.7 kcal/mol in SDPC and 18.3 kcal/mol in SOPC. Greater affinity for SOPC than 
SDPC is implied, which we ascribe to tighter packing within the monounsaturated 
phospholipid bilayer. The behavior resembles the higher affinity cholesterol has for 
ordered, saturated lipid-raft like environments. 
From the energy barrier at the center of the membrane in our PMF profiles, defined as  ∆𝐺z5EQ between zeq and z0, we further estimated the rate flip-flop rate for αtoc. The barrier 
is 0.7 kcal/mol higher in SOPC than SDPC, and the estimated flip-flop rates are 2.5×10¬ 
s-1 for the SOPC and 7.5×10¬ s-1 for the SDPC. Like cholesterol, the rates are much faster 
than reported for phospholipid [5,6]. The faster flip-flop of αtoc in SDPC is consistent with 
our result from standard MD simulation. The orientation of the chromanol group with 
respect to depth within the membranes was also mapped. These plots confirm that the 
chromanol group tends to stay “upright” except at the center of bilayer, where it becomes 
random in orientation and so can flip to the other leaflet.  
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Taken together, our umbrella sampling simulations found that αtoc binds less strongly to 
and flip-flops more quickly in SDPC than SOPC. Preferential affinity for polyunsaturated 
phospholipid is not seen. 
6.2 n-3 PUFA 
DPA (22:5), DHA (22:6) and EPA (20:5) are long chain n-3 PUFAs with differing lengths 
and numbers of double bond consumed in the diet from fish oils. They are associated with 
a lot of health benefits [7], but whether they have shared or complementary effect is 
unknown. Our purpose was to investigate how their uptake into phospholipids affect 
membrane organization and the interaction with cholesterol. In Chapter 5, we applied 
standard all-atom MD simulation on model membrane-water systems with validation by 
2H NMR order parameters. The membrane bilayers are composed of phosphatidylcholine 
(PC) with stearic acid for the sn-1 chain and different unsaturated fatty acids for the sn-2 
chain.  The sn-2 chain was either DPA, EPA, DHA or, as a monounsaturated control, OA. 
Each of these PC lipids were simulated twice: one on a bilayer composed 100 mol% PC, 
and another with 80 mol% PC and 20 mol% of cholesterol.  
The simulations run on single component bilayers showed that, as expected, all three 
polyunsaturated membranes were more disordered and thinner than the monounsaturated 
control. Among the polyunsaturated membranes DPA-PC was least disordered and thickest 
while EPA-PC was most disordered and thinnest. DHA-PC was in between. The interaction 
with cholesterol was investigated in three steps. First, we observed that cholesterol 
increases the order and thickness of the polyunsaturated PCs less than monounsaturated 
OA-PC. Less interaction between cholesterol and lipid chains in the more disordered 
membranes is implied. Then, we calculated two-dimensional RDFs for carbon atoms on 
the phospholipid chains (both sn-1 and sn-2) with respect to cholesterol. They showed the 
disordered n-3 PUFA chains pack around the sterol moiety less compactly than the more 
ordered saturated SA and, to less extent, mono-unsaturated OA chain. Finally, we 
generated 3D NDPs of carbons on the phospholipid chains around cholesterol. They 
confirmed that the n-3 PUFA chains at the sn-2 position do not pack as tightly around the 
sterol as SA at the sn-1 position or OA at the sn-2 position. Heterogeneity in the NDP 
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profile, indicating more intimate sterol-FA chain interaction, was most visible for QA-PC, 
and gradually faded away with more disordered n-3 PUFA-containing PCs.  
In general, our simulations and analysis show all three PUFAs disorder the membrane and 
interact less favorably with cholesterol than OA or SA. EPA has the most disordering effect 
and packs least well with cholesterol, while DPA has the least disordering effect and packs 
most well with cholesterol. Such differences have the potential to differentially modulate 
plasma membrane organization, for example regulating the size of lipid rafts and so 
modulating the activity of signaling proteins. The results demonstrate, in particular, that 
possible elongation of EPA to DPA must be taken into account when interpreting the 
impact of fish oils on membrane organization [8]. 
6.3 Future directions 
Future directions for research include further study of the binding of αtoc to lipid bilayers 
and its flip-flop within membranes. 
The comparison of binding energy measured for SDPC vs. SOPC in our UBSMD 
simulations shows αtoc has greater affinity to the less unsaturated lipid. However, in these 
simulations αtoc is in a single component phospholipid environment. Plasma membranes, 
by contrast, contain many different lipids. Cholesterol, in particular, is a major constituent 
and its concentration varies drastically between lipid domains. It is possible that αtoc would 
prefer a PUFA-rich environment depleted in cholesterol over a saturated raft-like domain 
enriched in cholesterol concentration. Thus, a future direction is to obtain the binding 
energy of αtoc cholesterol-containing membranes. We would prepare lipid membranes 
composed of SDPC or SOPC, mixed with different concentrations of cholesterol. A pair of 
αtoc would then be placed in the membranes to perform UBSMD simulations like in 
Chapter 4, to so get its binding energy in the presence of cholesterol. 
The path that αtoc takes in the flip-flop process would be better described by adding the 
orientation of the chromanol group as another reaction coordinate in the umbrella sampling. 
A similar approach was done in studying cholesterol’s flip-flop behavior [6]. As another 
future direction, we propose performing two-dimensional USMD simulations to get the 
profile of the PMF G(z,θ) for αtoc as a function of both depth z and orientation θ of the 
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chromanol group. In this way we would get a more complete analysis of αtoc’s flip-flop 
motion. The same two-dimensional USMD method could also be applied to δ-tocopherol, 
which undergoes much slower flip-flop according to our earlier all-atom simulations.  
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APPENDIX A. SUPPLEMENTAL MATERIAL FOR ALPHA-
TOCOPHEROL IS WELL-DESIGNED TO PROTECT 
POLYUNSATURATED PHOSPHOLIPIDS: MD SIMULATIONS 
Table A.1 
The surface area per lipid calculated from the average bilayer size during the MD 
simulations on SDPC and SOPC bilayers in the absence and presence of 20 mol% αtoc at 
37 °C. 
 
Lipid 
 
 
SDPC 
 
SDPC+αtoc 
 
SOPC 
 
SOPC+αtoc 
 
Area/lipid 
(Å2) 
 
 
71.7 ± 0.2 
 
62.4 ± 0.2 
 
65.7 ± 0.3 
 
58.7 ± 0.2 
 
The uncertainties are the standard error of the areas. 
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Figure A.2 
FFT depaked2H NMR spectra for 50 wt% aqueous dispersions in 50 mM Tris buffer (pH 
7.5) of (a) SOPC-d35, (b) SOPC-d35 + 20 mol% αtoc, (c) SDPC-d35 and (d) SDPC-d35 + 20 
mol% αtoc at 37 °C. 
 
 
 
 
 
 
 
 
 
 
 
 
140 
 
 
 
Figure A.3 
Order parameter profiles along the sn-1 chain in SDPC (left panels) and SOPC (right panels) 
at 37 ºC obtained in the absence (○) and presence (x) of 20 mol% αtoc from MD 
simulations (upper panels) and FFT depaked 2H NMR spectra (lower panels). 
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Figure A.4 
Measured structure factors for SOPC (18:0-18:1 PC) and SDPC (18:0-22:6 PC) 
membranes containing protiated αtoc (red) and C5 deuterated αtoc (black), under 94% 
relative humidity hydration at 37 °C. The solid squares are the measured, phased and scaled 
structure factors and the line is the fit of Shannon’s Theorem generating a continuous form 
factor.  
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Figure A.5 
Scaled neutron scattering length density profiles for SOPC (18:0-18:1 PC) and SDPC 
(18:0-22:6 PC) with 20 mol% protiated αtoc (red) and 20 mol% αtoc-d3 (black) hydrated 
with 8% D2O at 37°C. The green line is the C5 deuterium label distribution and the blue 
line represents the water distribution vertically scaled down by a factor 5. 
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Table A.2 
Measured (unit cell) and calculated (other) structural parameters for α-[5-2H3]tocopherol 
(αtoc-d3) in SOPC (18:0-18:1 PC) and SDPC (18:0-22:6 PC) membranes at 37 °C. 
Phospholipid Unit 
Cell 
Bilayer 
Thickness 
Water 
Centre* 
Water 
Width 
Label 
Centre* 
Label 
Width 
18:0-18:1 PC 53.8±0.3 38.8±0.2 26.9±0.1 10.6±0.5 21±1 6.2±0.3 
18:0-22:6 PC 50.5±0.9 35±1.6 25.3±0.3 9.9±0.5 19±1.5 8.3±4 
 
*Label position is relative to the bilayer center, and the range that it occupies is determined 
from the widths, 1/e, of Gaussian fits to the data. Units are angstroms (Å). 
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APPENDIX B. SUPPLEMENTAL MATERIAL FOR ALL N-3 
PUFA THE SAME? A COMPARISON OF EPA, DHA AND DPA 
BY MD SIMULATIONS 
B.1 Solid state 2H NMR spectroscopy 
B.1.1 Materials 
1-[2H35]stearoyl-2-oleoylphosphatidylcholine (OA-PC-d35), 1-[2H35]stearoyl-2-
eicosapentaenoylphosphatidylcholine (EPA-PC-d35), 1-[2H35]stearoyl-2-
docosapentaenoylphosphatidylcholine (DPA-PC-d35), and 1-[2H35]stearoyl-2-
docosahexaenoylphosphatidylcholine (DHA-PC-d35) with a perdeuterated sn-1 chain were 
bought from Avanti Polar Lipids (Alabaster, AL). They were either a stock item or custom 
synthesized. Sigma (St. Louis, MO) and Cambridge Isotope Laboratories (Andover, MA), 
respectively, were the source of cholesterol and deuterium depleted water. 
B.1.2 Sample preparation 
Phospholipid (25 mg), on its own or co-dissolved with cholesterol (20 mol%), in 
chloroform solution was dried with a gentle stream of argon gas (nitrogen gas for OA-PC-
d35) and vacuum pumped overnight to remove residual organic solvent. Samples (50 wt% 
lipid) were hydrated with 50 mM Tris buffer, vortex-mixed and pH was adjusted to 7.5. 
They were then lyophilized three times with deuterium-depleted water to remove trace 
amounts of 2HHO. The samples were finally rehydrated with deuterium-depleted water and, 
following 3 cycles of freezing and thawing, were transferred to 5 mm NMR tubes and 
stored at -80 °C. Precautions were taken throughout the procedure to minimize oxidation 
of the samples containing polyunsaturated phospholipid - exposure to direct light was 
limited and manipulations were performed in a glove box purged with argon gas [1]. 
B.1.3 NMR spectroscopy 
Solid state 2H NMR spectra were acquired on a homebuilt spectrometer operating 
at 46.0 MHz with a 7.05 T super-conducting magnet (Oxford Instruments, Osney Mead, 
UK) [2]. As previously described, pulse programming was accomplished with an 
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programmable pulse generator assembled in house, a phase-alternated quadrupolar echo 
sequence (90°x-τ-90°y-acquire-delay)n was implemented, signals were obtained in 
quadrature using a R1200 dual-channel digital oscilloscope (Rapid Systems, Seattle, WA) 
and temperature was monitored to ±0.1 °C with 1600 Series controller (Love Controls, 
Michigan City, IN). Parameters were 90° pulse width = 3.6 µs; separation between pulses 
τ = 50 µs; delay between pulse sequences = 1.5 s; sweep width = ±100 kHz; dataset = 2 K; 
and number of transients = ~15,000. 
B.1.4 Spectral Analysis 
 The FFT depaking algorithm was applied to enhance resolution of the NMR spectra 
that are superposition of signals from all positions in the perdeuterated chain at the sn-1 
position on a phospholipid [3]. The resultant spectra, equivalent to a planar bilayer aligned 
with its normal in the same direction as the magnetic field (𝜃 = 0°), consist of a series of 
doublets that are each split according to the magnitude of the order parameter 𝑆"# for a C-
2H bond. Smoothed profiles of order along the sn-1 chain were then generated on the basis 
of integrated intensity assuming the value of 𝑆"#  monotonically decreases toward the 
terminal methyl group [4] 
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Figure B.1 
FFT depaked 2H NMR spectra at 37 °C for 50 wt% aqueous multilamellar dispersions of 
OA-PC-d35, DPA-PC-d35, DHA-PC-d35 and EPA-PC-d35 in 50 mM Tris (pH 7.5). 
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Figure B.2 
Smoothed order parameter profiles constructed for the sn-1 chain in OA-PC-d35, DPA-PC-
d35, DHA-PC-d35 and EPA-PC-d35 from FFT depaked 2H NMR spectra at 37 °C. 
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